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ABSTRACT
Background: Unity in pursuit of the Triple Aim: better health, better care, and lower
per capita cost, can be achieved through a well-designed health care delivery system. The
accountable care organizations (ACOs) model is considered a key component of health care
delivery system improvement because the model fosters better coordination of care through
clinical integration and financial accountability.
Within the six Centers for Medicaid & Medicare Services (CMS) ACO programs, the
Medicare Shared Savings Program (MSSP) ACO has the largest size with a total of 432
ACOs formed; the service subjects of the MSSP ACO are the fee-for-service beneficiaries.
Recently, academicians and researchers have been attracted to exploring ACOs’ formation
and performance. However, most of the early ACO research types are either descriptive or
case study. Also, early researchers had limited access to ACO data sets, so they could utilize
only regional and demographic factors to identify the predictors of ACO formation.
Purpose: An integrative theoretical framework, Rogers’ diffusion of innovation theory
and Duncan’s POET model, was used to examine ACO formation and performance. The first
purpose of this study was to determine the relative influences of contextual variables and
ACO characteristic variables on how early an ACO model was adopted. The second purpose
was to examine how executives’ perceptions of ACO performance and the ACO first-year
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performance are influenced by the contextual variables, ACO characteristic variables, and
timing of the adoption of an ACO model.
Methods: A cross-sectional design was formulated to gather data from a survey
supplemented by secondary data with the analysis unit at the organization level. Study
participants in the ACO survey included 2012, 2013, 2014, and 2015 ACO cohorts. Logistic
regression was performed to examine the effects of POET and Rogers’ five core
characteristics in the early adoption of an ACO model (dichotomous). Additionally, multiple
linear regression analysis was used to examine the effects of POET and the timing of
adoption of an ACO model in the perceptions of ACO performance. ACO first-year
performance dataset consisted only of ACO cohorts from 2012 through 2014. Finally,
confirmatory factor analysis and structural equation modeling were conducted to examine the
measurement model of the ACO first-year performance and a full latent variable model,
respectively.
Major Findings: A survey of ACO executives/managers between October 2015 and
February 2016 was conducted. The 447 MSSP ACOs in my mailing list yielded a response
rate of 13.65 % (n=61). Of the 61 MSSP ACOs, 42 (52.5%) were late adopters whose
contractual agreement with CMS started in 2014 or 2015, and 36 (59.0%) were with hospitalbased composition. Among ACOs that participated in my survey, their current degree of IT
adoption in functionalities (62.27 vs. 52.50 points), usage levels (65.19 vs. 49.49 points), and
iii

integration levels (62.24 vs. 53.37 points) were better than their initial years. The multiple
logistic regression presented that MSSP ACOs were more likely to be early adopters of a
CMS if their service areas had high unemployment rates (OR=2.23; 95% CI: 1.13 - 4.39). In
the multiple linear regression analysis, the executives in the early ACOs perceived their
organizations as more effective than the late adopters, with 12.65 points higher in an
aggregate of eight ACO quality domains (p = .005).
Three hundred and seventeen MSSP ACOs, with contractual agreements with CMS
before 2015, had retained their year-one performance records (the actual ACO performance
with eight quality domains). The variability in the actual ACO performance was explained by
the predictor variables of the study with an R-square of 15%. The actual ACO performance
was likely to be improved if ACOs had more Medicare assigned beneficiaries or had the
hospital-based composition. On the other hand, if ACOs’ service areas were located in areas
of high poverty concentration, a high unemployment rate, or a lower competitive index, their
ACO performance was relatively lower than their counterparts.
Implications: The findings suggest that managers should consider strategies to
increase economies of scale in size and to have hospital involvement in their ACOs in order
to increase effective management. Inadequate capital for information technology
improvements is the biggest barrier inhibiting healthcare providers’ willingness to join an
ACO. Regardless of rural or urban areas, financial support is still important for those
iv

potential ACO participants who are planning to invest in necessary infrastructure. ACOs that
involved hospitals also showed better performance than those ACOs without hospital
involvement. This information may help health policy makers to define core principles of the
best ACO model in the future.
Conclusions: This study makes a unique contribution using a theoretically integrative
framework with Rogers’ diffusion of innovation theory coupled with Duncan’s POET model
to examine ACO formation and ACO performance. In the early ACO adopters, three-fifths of
the ACOs had hospital involvement; and the levels of their current IT degree in
functionalities, usage levels, and integration levels are higher than the late ACO adopters.
This study demonstrates that contextual variables, such as unemployment rates at ACO
service areas, relatively influence how early an ACO model was adopted. Executives in the
early ACOs had higher perceptions of overall organizational effectiveness as compared with
the late adopters. The first-year performance of 2012, 2013, and 2014 ACO cohorts is
positively influenced by the size of assigned Medicare beneficiaries and hospital-based ACO
and is negatively influenced by the poverty rate, unemployment rate, and market competition
scores (Herfindah-Hirschman Index).
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CHAPTER ONE INTRODUCTION
Background on Health Policy
Among the Organization for Economic Co-operation and Development (OECD)
countries, the United States has the lowest public health insurance coverage rate, with 28%
(Squires, Osborn, Thomson, & Jun, 2013) and approximately 35.28 million Americans
without health insurance, according to data from the second quarter of 2015 (Obamacare
Facts, 2016). Improving health is always of utmost importance for every country. Health is
influenced directly by health determinants, which include: 1) physical environments in which
people live and work; 2) behavioral choice and biology; 3) social factors, such as economic
circumstances and socioeconomic status; and 4) access to health services (Longest, 2010).
These health determinants are influenced by health policy, so health policy has an indirect
impact on people’s health. For instance, because the passage of Medicare and Medicaid in
1965 increased access to health services, the health of the Medicare and Medicaid
beneficiaries has since been improved (Centers for Medicare and Medicaid Services (CMS),
2013a).
In the past decades, the patient care approach was changed from disease-oriented to
patient-centered care, but its focal point still revolves around disease or infirmity. The
Institute for Healthcare Improvement (IHI) (2015) recognized a new need for health care in
the current decade, so IHI proposed the Triple Aim concept to optimize health system
performance. Triple Aim tries to achieve better health, better care, and lower per capita cost.
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When President Obama signed the Affordable Care Act (ACA) on March 23, 2010, the
window of health reform was opened. The ACA also includes the key features that are
consistent with the Triple Aim of IHI, such as improving quality, lowering health care costs,
increasing access to health care, and providing new consumer protections (U. S. Department
to Health & Human Services, 2015).
In the United States, more than 50 million elderly and disabled Americans are covered
by Medicare. Reducing unnecessary health care spending for Medicare beneficiaries is the
US government’s goal. Five major factors attributed to health care costs are: aging
population/closeness to death; new technologies; incomes; health care delivery system; and
diet, health, and lifestyle. The health care delivery system factors include institutions and
supply of health care, relative prices, and the design of reimbursement systems (Martin,
Lopez del Amo Gonzalez, & Garcia, 2011; Rice & Unruh, 2015; van Elk, Mot, & Franses,
2010; Kuttner, 2008). The Patient Protection and Affordable Care Act (PPACA) employed
strategies shaping the health care delivery system to reduce unnecessary and wasteful medical
utilizations in the Medicare beneficiaries population, such as implementing Accountable Care
Organizations (ACOs) and reformed payment systems (Wechsler, 2012).
Transforming Into a Coordinated Care Delivery System
Unity in pursuit of the Triple Aim can be achieved through a well-designed health care
delivery system. The ACO model is considered a key component of health care delivery
system improvement because the model fosters better coordination of care through clinical
2

integration and financial accountability (Press, Michelow, & MacPhail, 2012). Early results
show that the collaborative ACO model has a trend of providing better quality care and lower
costs (Salmon et al., 2012). Also, patients in early adopter ACOs had better performance in
Medicare spending, hospitalizations for COPD/Asthma, and some measures of patients’
experiences, compared with those patients in non-ACOs (McWilliams, Chernew, Landon, &
Schwartz, 2015; McWilliams, Hafield, Chernew, Landon, & Schwartz, 2016; McWilliams,
Landon, Chernew, & Zaslavsky, 2014). Better care coordination will improve quality at any
given cost, particularly for those who have multiple chronic conditions requiring effective
coordinated care (Burns & Pauly, 2012). As health care providers share only basic electronic
data across providers, the meaningful usage level for coordinated care is not optimal.
Therefore, McClellan et al., (2014) defined the best coordinated care as the adequate clinical
and data integration within a provider network. In order to generate net savings among
Medicare beneficiaries, essential elements of continuity in a coordinated care system has to
be transformed to ensure that patients receive the coordination and continuity of health care
across clinical settings or different levels of care within the same setting (Peikes, Chen,
Schore, & Brown, 2009).
Early Accountable Care Organization Studies
Recently, academicians and researchers have been attracted to exploring how ACOs are
formed and evaluated for their performance. Fisher and colleagues (2012) pointed out that a
comprehensive evaluation of ACO framework should include certain important factors, such
3

as local context, contract characteristic, and organizational structure, capabilities, and
activities. In order to understand the process of health care providers joining an ACO model,
the majority of early ACO studies are descriptive or case studies that look at, for example,
where ACOs have formed. Another ACO study of this type identified ACOs as three-cluster
based on their size and scope of service offered: Physician-led ACO, Integrated Delivery
System (IDS) ACO, and Hybrid ACO (Shortell, Wu, Lewis, Colla, & Fisher, 2014).
Additionally, in order to collect larger sample sizes, researchers often included all kinds of
ACOs in their analysis, such as Medicare, Medicaid, and Commercial Payers ACOs (Shortell
et al., 2014; Auerbach, Liu, Hussey, Lau, & Mehrotra, 2013; Lewis, Colla, Carluzzo, Kler, &
Fisher, 2013). However, the mixed types of ACOs might provide limited suggestions
pertaining to specific ACO formation and performance.
Early studies identified some determinants of ACO formation, but their findings were
inconsistent. For instance, one study found the characteristics of hospital service areas
influenced ACO formation (Lewis et al., 2013). Another study placed emphasis on joining an
integrated care system (Auerbach et al., 2013). Also, Lewis et al., (2013) and Auerbach et al.,
(2013) had limited access to ACO datasets, so they could utilize only regional and
demographic factors to identify the predictors of ACO formation. Some recent studies
reported initial results of ACO early performance assessment in savings, quality, cost, and
patients’ experiences, and these studies focused on the effects of an ACO model intervention.
4

Therefore, of these studies, one study applied the two-group post-test design at the facility
level, whereas two other studies utilized the two-group pre-post test design at the patient level
(McWilliams et al., 2014; McWilliams et al., 2015; Epstein et al., 2014). The remaining study
utilized only one-group pre-post design to examine the performance of three cases in their
uses of the Commercial-type ACO model (Salmon et al., 2012).
The year-one performance dataset of the Medicare Sharing Savings Program (MSSP)
ACO was released by the Centers for Medicare and Medicaid Services (CMS) at the end of
2014 for the 2012 and 2013 ACO cohorts. Also, the year-one performance of the 2014 ACO
cohort was available at the end of 2015. This recent dataset includes useful information, such
as ACO models’ basic information, generated savings/losses, and 33 ACO performance
indicators, which allows my research to link performance variables at the ACO level. In the
MSSP ACO model, all ACOs must meet the 33 quality care indicators in order to gain
savings from CMS. In other words, police makers expect an ACO model’s performance is
better than the non-ACO model. Additionally, ACOs can develop their own best coordinated
care through certain management strategies or tools that tailor their population’s health needs.
Therefore, my research, which explores factors influencing ACO model performance will
make valuable contributions to health care management policy making.
Diffusion of Innovation Perspective and POET Model
Diffusion can be considered a type of social change. Take health care reform, for
example. When an ACO model is invented, diffused, and adopted or rejected, this set of
5

actions leads to certain consequences and social changes. In order to explain why and how an
ACO model has been adopted, Rogers’ (1995) diffusion of innovation is useful for
investigating its formation and performance. According to the diffusion of innovation theory,
an ACO model can be defined as an innovation because this model will be perceived as a new
idea by the stakeholders in health care, such as health care providers, payers, employers, and
patients. The four main elements of the diffusion of innovation theory are the characteristics
of innovation, communication channels, time, and the social system. Rogers’ (1995)five
theoretical core characteristics of diffusion are important in explaining the rate of adoption
and how these characteristics are perceived by an individual or other unit of adoption
(Rogers, 1995). When it comes to ACO model adoption, health care providers can be the
measured subjects, but executives of ACOs also are considered important opinion leaders and
key informants in providers. Accordingly, executives’ perceptions of and beliefs about
operating an ACO model are essential to understanding the formation and growth of ACOs as
an innovative model of coordinated care.
Overall, the perceived characteristics of an ACO model that are identified by
executives of ACOs include: greater relevance and relative advantage, compatibility,
trialability, observability, and less complexity. Any of these characteristics might contribute to
an ACO model being adopted. Rogers (1995) claims that potential adopters might be more
familiar with an innovation if they are made aware of the existence of an innovation through
6

mass media. The relative point in time at which innovations are adopted can be grouped into
five categories: innovators, early adopters, early majority, late majority and laggards. Not
only do individuals directly influence the innovation adoption, but also social systems affect
adoption. Moreover, social systems also indirectly influence the innovation adoption through
individuals. Duncan’s ecological complex model (1959), including population (P),
organization (O), environment (E) and technology (T), or POET, fits well in explaining how
contextual factors contribute to social change and the diffusion of new ideas. These four
societal factors function as a dynamic mechanism for fostering changes and performance
improvement in health. In this research, the POET model will be integrated with the diffusion
of innovation theory in order to examine why an ACO model was adopted and how the ACO
model is performing.
Research Questions
In order to understand the diffusion of an ACO model’s formation and its performance,
the primary aim of my research was to examine the relative influences of contextual factors
and the characteristics of an ACO model on the timing of an ACO model adoption. The ideal
goal for ACOs is to improve beneficiaries’ quality of care. However, little is known about the
factors influencing an ACO model’s performance. Thus, the secondary aim of my research
was to determine how an ACO model’s performance (both perceived and actual performance)
is influenced by the contextual variables, the characteristics of an ACO model, and the timing
of such an adoption.
7

Significance of the Present Study
By studying the formation and transformation of the delivery system into ACOs, my
research provides useful strategies for increasing the formation of ACOs in those areas with a
relatively lower adoption rate. Additionally, my study provides insights about the factors
influencing the variability in the ACO’s performance. Thus, information from my research
can be provided to CMS to show how ACOs are able to optimize cost reduction and improve
quality of care.
Outlines of Remaining Chapters
The application of the diffusion of innovation in the formation of the ACOs model is
introduced in the beginning of Chapter 2. The following part describes some studies
regarding the diffusion of innovations in health care. The second part of Chapter 2 covers the
definition of accountable care programs and summarizes the primary differences between six
different types of ACO programs in the CMS. The size of the MSSP ACO is the largest
among the six ACO programs with a total of 432 ACOs formed, so the MSSP ACO’s growth
in size and medical beneficiaries served is described in five performance periods. The third
part of Chapter 2 reviews the opportunities and challenges of ACOs for health care providers.
At the end of Chapter 2, particular attention is directed toward modeling accountable care
organizations and achieving success in an ACO model.
Chapter 3 presents theoretical formulation using Rogers’ diffusion of innovation theory
and Duncan’s POET model to guide two major research aims: the timing of an ACO model
8

adoption and an ACO model’s performance. In order to derive the deduction of the theoretical
hypotheses in the timing of an ACO model adoption, this chapter reviews the literature which
that revealed the empirical factors affecting innovation adoption in the health care field.
These studies included the aspect of the contextual characteristics and adopters’ attitudes and
beliefs regarding the adoption. For the hypotheses of an ACO model’s performance, the
relatively controllable factors are the focus of the literature review, such as institutional
leadership models, information infrastructure’s functionalities and usage levels, and the
timing of an ACO model adoption. Finally, eight initial research hypotheses are derived based
on the research framework.
Chapter 4 begins to explain the study design and participants. It also describes how the
five data sources are merged and identify their corresponding variables. The operational
definitions and measurement instruments are provided with detailed explanations presented
for each research aim. The section focusing on data analysis for the first and second research
aim includes descriptive analysis, logistic regressions, and multiple linear regressions.
Additionally, confirmatory factor analysis and structural equation modeling (SEM) are
presented for the third research aim. At the end of this chapter, model evaluation of goodnessof-fit and prior sample size estimations are discussed.
Chapter 5 describes the results of my ACO survey and the ACO year-one performance
data. The first section concerns an ACO survey that covers non-response bias, respondent
9

characteristics, predictors of the early adoption of an ACO model, and predictors of the
perceptions of overall organizational effectiveness. The second section presents the results of
ACO year-one performance in terms of the measurement model and the covariance structure
model. A brief summary of findings is given in the final section of this chapter.
Chapter 6 presents the results of individual hypothesis testing and interpretation by
research aims. At the end of this chapter, limitations of the study are shown in terms of
various sample sizes and a lower response rate. Finally, Chapter 7 presents imperative
implications of these research findings for researchers in the evaluation of national
demonstration programs, healthcare executives/ managers, and policy makers. At the end of
this chapter, several ideas for future research and significance conclusions are presented.
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CHAPTER TWO BACKGROUND AND LITERATURE REVIEW
This literature review consists of six sections. The first section discusses the diffusion
of innovation theory applicable to the formation of an ACO model. In addition, some study
findings regarding the diffusion of innovations in health care are listed in the second section.
The third section provides the overview of accountable care programs and ACO program
types in the centers for Medicare and Medicaid services. The fourth section focuses on the
Medicare Shared Savings Program (MSSP) ACO and its growth. The opportunities and
challenges of ACOs for health care providers are described in the fifth section. The last
section discusses modeling ACOs and achieving success in an ACO model.
Diffusion of Innovation Theory Applicable to Formation of ACO Model
As of September 2011, an early survey by Audet, Kenward, Patel, & Joshi (2012)
showed that only 13 percent of hospitals, who were at the initial stage of the ACO adoption,
reported participating in an ACO or planning to participate within a year. Of those hospitals,
their top four payer partnerships are contracting with commercial payers, the Pioneer ACO
program, Medicaid ACO program, and Medicare Shared Savings program. . In 2014, the
CMS expected that only 50 to 270 ACOs would be participating in the Medicare Shared
Savings program by the end of the year 2015 (Lewis, 2012), but the actual number of ACOs
that participated in 2015 was greater than CMS had predicted. As of the fifth performance
period (January 1, 2015), 432 ACOs have covered 7.8 million Medicare beneficiaries and 35
million non-Medicare patients, but ACO formation varies among different areas (Oliver
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Wyman Press Release, 2015). The ACOs growth phenomenon raises an interesting issue
pertaining to the factors driving an organization to be an early adopter of an ACO.
Early studies identified some determinants of ACOs formation, but their findings were
inconsistent. Lewis and colleagues (2013) found hospital service area characteristics are
positively related to ACO formation, such as higher performance on quality, higher Medicare
per capita spending, fewer primary care physician groups, greater managed care penetration,
and urban location. Contrary to this, Auerbach, et al., (2013) emphasized that the key factor
associated with ACO formation is joining an integrated care system, such as a larger
integrated hospital system and primary care physicians practicing in large groups . Epstein et
al., (2014) showed that hospitals having a large quantity of beds is an important factor of
forming an ACO. These studies focused somewhat more on environmental and organizational
factors. However, in the innovation-decision process, individuals’ (or the decision making
unit) attitudes toward the ACO model directly influenced a decision to adopt or reject the
ACO model (Rogers, 1995). In order to comprehensively explain why and how an ACO
model has been adopted, Rogers’ (1995) diffusion of innovation is useful in portraying its
formation.
In Rogers’(1995) diffusion of innovation theory, an innovation is defined as “an idea
perceived as new by an individual or other unit of adoption”(p. 10-11), and diffusion is
defined as “the process by which an innovation is communicated through certain channels
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over time among the members of a social system” (p. 10-11). Health care stakeholders
considered an ACO model an innovation because they perceived this model as a new
approach to delivering coordinated care for patients. Based on this theory, the characteristics
of innovation, communication channels, time, and the social system (context) are four main
elements in the diffusion of innovations. In other words, the ACO formation might also be
influenced by these elements.
Of these elements, Rogers’ (1995) five core characteristics of innovation are the
common foundations for developing my survey for examining an ACO formation. These
characteristics of innovation include relative advantage, compatibility, complexity,
trialability, and observability. The degree to which an ACO model is perceived as gaining
more advantages than using a traditional health care delivery approach could be seen as a
relative advantage in the five core factors of innovation. The degree to which an ACO model
is perceived as being consistent with existing values, past experiences, and needs of potential
adopters could be seen as a compatibility factor. An ACO model that is difficult to learn and
operate could be seen as a complexity factor. The degree to which an ACO model can be tried
on the installment plan could be seen as a trialability factor. The degree to which executives
can observe that other healthcare providers participating in an ACO model could be seen as
an observability factor. Individuals consider ACO models with greater advantage,
compatibility, trialability, observability, and less complexity favorably, and these
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characteristics can explain why the individual or agency adopt early.
Diffusion of Innovations Studies in Health Care
Diffusion theory provides a possible explanation for innovation adoption (SansonFisher, 2004). In the health care industry, Rogers’ (1995) five theoretical core characteristics
of diffusion are widely applied to understand client or clinical settings’ barriers to adopting an
innovation regarding Information Technology (IT), except when it comes to adopting an ACO
model. Two common approaches to measuring Rogers’ (1995) five theoretical core
characteristics of diffusion are face-to-face or phone interviews and questionnaires. How
individuals value innovation characteristics varies greatly between innovations, but perceived
attributes by individuals have a significant effect on adoption of an innovation. Of these prior
studies, adopters and non-adopters usually have different perceptions of an innovation. Also,
out of these five core characteristics, complexity, compatibility, and observability are the
critical common factors influencing the adoption decision. Next, more detail is provided
explaining why some innovations had low adoption rates are described as follows.
Compared with non-adopters, adopters had critical differences in their perceptions of
telemedicine in terms of relative advantage, compatibility, and trialability (Spaulding, Russo,
Cook, & Doolittle, 2005). Additionally, adopters’ attitudes and beliefs regarding electronic
medical records also are different from non-adopters. For example, adopters believe that
physicians should computerize their records, and current electronic medical records (EMRs)
are a useful tool to physicians that paper records are more secure (Loomis, Ries, Saywell, &
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Thakker, 2002).
Chew and colleagues (2004) pointed out that Rogers’ five innovation attributes can
predict adoption of innovation, and the relative advantage and trialiability factors accounted
for 31% adjusted variance for internet use. Perceived usefulness is the strongest factor in
influencing the attitude toward electronic health records adoption, and the usefulness factor is
influenced by individuals’ perceived complexity factor (Morton, & Wiedenbeck, 2009).
Sams, Rozier, Wilder, & Quinonez’s (2013) national survey showed that a high relative
advantage and low complexity have a strong influence on oral health initiative adoption
decisions. Additionally, in Pronk et al. (2002), Dutch pharmacists perceived observability,
compatibility and trialability of the innovation the most important factors influencing the
adoption of the new strategy regarding patient oriented activities. Hsu, Liu, Weng, and Chen
(2013) found that factors influencing nurses’ intentions toward the use of mobile electronic
medical records included observability, compatibility, and complexity. Of these, observability
had the most significant effect. Finally, Peeters, de Veer, van der Hoek, and Francke (2012)
considered the observability factor the most important factor in determining the adoption of
home telecare.
In order to explain a low uptake of the health data standards in Saudi Arabia, Alkraiji,
Jackson, & Murray (2013) found that the main reasons include: (1) Saudi Arabia is a
newcomer in the advanced medical IT system, so respondents perceived a high complexity
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attribute; (2) Saudi Arabian potential adopters also perceived a low compatibility attribute
because they considered their ability to develop technical infrastructure and the different
work environment and culture with different participants. And finally, (Makowsky, Guirguis,
Hughes, Sadowski, and Yuksel (2013) noted that pharmacists are likely to adopt electronic
prescribing because the adoption increases their sense of professionalism, the professional
image, and job satisfaction.
Introduction of Accountable Care Programs
CMS (2013b) asserted that “Accountable Care Organizations (ACOs) are groups of
doctors, hospitals, and other health care providers, who come together voluntarily to give
coordinated and high quality care to their Medicare patients”. According to the requirements
of section 1115A of the Social Security Act, the CMS Innovation Center develops several
models to achieve better care for patients. Accountable Care is one of seven categories in
innovation models.
CMS offers six ACO programs, and one of them is the disease-specific End-Stage
Renal Disease (ESRD) program. Among these ACO programs, the earliest ACO program is
the Pioneer ACO model, which began on January 1, 2012. The ACO Investment model and
the Next Generation ACO Model are the newest ones, which started their first cycles on
January 1, 2016. The MSSP and Advance Payment ACO had a start cycle date of April 1,
2012 (CMS, 2015a).
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Table 1 Types of ACO Programs in CMS
Type

Initial Start Cycle

Providers’ Characteristics or
Service Target



Pioneer ACO model

January 1st, 2012

Health care organizations and
providers who have
experiences in coordinating
care



Advance Payment ACO

April 1st, 2012

Physician-based and rural
providers



Medicare Shared Savings
Program (MSSP)

April 1st, 2012

Fee-for-service beneficiaries



Comprehensive ESRD Care
Initiative

July 1st, 2015

Medicare beneficiaries with
End-Stage Renal Disease
(ESRD)



ACO Investment model

January 1st, 2016

Encouraging new ACOs to form
in rural and underserved areas
and existing ACOs to move to
high risk tracks



1. January 1st, 2016
Next Generation ACO Model
(for three
performance
periods)
2. January 1st, 2017
(for two
performance
periods)

Health care organization and
providers who receive higher
levels of financial risk and
reward than the Pioneer
Model and MSSP.

The primary differences between the six ACO programs are providers’ characteristics
and service areas/subjects. For more detailed information, please see Table 1. For instance,
the Pioneer ACO model is designed for health care organizations and providers who have
experiences in coordinating care. Physician-based and rural providers can apply to the
Advance Payment ACO model. The ACO Investment Model is designed to encourage new
ACOs to form in rural/underserved areas and existing ACOs to move to high risk tracks. The
service subjects of the MSSP ACO are the fee-for-service beneficiaries. Until January 1,
17

2015, the size of the MSSP ACO was the biggest among the six ACO programs with a total of
432 ACOs formed.
Medicare Shared Savings Program (MSSP) ACO and Its Growth
The CMS designs the Medicare Shared Savings Program (MSSP) to incentivize ACOs
to improve care of Medicare Fee-For-Service (FFS) beneficiaries. ACOs can apply either the
lower risk or higher risk MSSP in terms of sharing the generated savings when ACOs service
at least 5,000 beneficiaries. These assigned beneficiaries must receive at least one primary
care service within the ACO from primary care physicians, other physicians, or certain nonphysician practitioners, including nurse practitioners, clinical nurse specialists, and physician
assistants (CMS, 2011).
On January 1, 2015, the CMS began implementing the fifth performance period of
MSSP. All five periods are still in the process of implementation. The size of the MSSP ACO
and accumulated number of Medicare beneficiaries in these periods are listed in Table 2
(CMS, 2015b). In the first performance period, only 27 ACOs have joined in the MSSP. In
the four following performance periods, the number of ACOs participating in the MSSP
steeply climbed to 432. The ACOs’ growth rate reached 1,500% at the January 1, 2015 start
of the fifth performance period. Having joined during the first four performance periods, 338
ACOs served 4.9 million Medicare beneficiaries in 47 states plus Washington DC and Puerto
Rico (CMS, 2013c). Once 89 new ACOs have participated in the fifth performance period, all
MSSP ACOs will have covered 7.8 million Medicare beneficiaries (Radnofsky & Beck,
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2015).
Table 2 The Size of the Medicare Shared Savings Program ACO in Five
Performance Periods
The start date of
Number
Accumulated number of Medicare
performance period
of ACOs
beneficiaries served
April 1st, 2012

27

375,000

July 1st, 2012

87

1.5 million

January 1st, 2013

106

2.2 million

January 1st, 2014

123

4.9 million

January 1st, 2015

89

7.8 million

Opportunities and Challenges of ACOs for Health care Providers
When health care providers perceived more barriers than benefits in an ACO model,
their willingness to participate in an ACO decreased (Wan, Masri, & Ortiz, 2014). From the
health care provider perspective, an ACO model provides an ideal opportunity to promote a
provider-provider partnership, creating real coordination of care, gaining savings, and
enlarging their market share. On the other hand, an ACO model also has potential challenges
for health care providers, such as: high-cost investment in information systems, incompatible
information systems, and less physician autonomy. All of these factors influence how health
care providers value an ACO model. In the following section, I provide a detailed description
of opportunities and challenges of any ACO model.
Opportunities.
Promoting a provider-provider partnership. ACOs provide an opportunity to form
working partnerships between physicians and hospitals. Hospitals are still central in an ACO
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model because of its potential avoidable Medicare costs and its ability to carry out the model
(Goldsmith, 2011). The role of physicians in the relationship with hospitals is changing from
customers to competitors, and then to partners. Certain providers, who have been isolated
from mainstream health care providers, also can gain a new platform for working with other
providers because they are considered valued partners in ACOs (Lewis, Colla, Schoenherr,
Shortell, & Fisher, 2014).
Coordinating care. All health care partners that join an ACO can gain access to their
patients’ claim data within their accountable care organizations, so health care providers can
know what services patients have received. This helps providers achieve better coordination
of care, especially among psychiatric providers (Yeung, Burns, & Loiacono, 2011; Batson &
Batson, 2015). A fully grown and developed ACO not only includes clinical partners, but
also, it includes nonclinical ones in a care team to address social and community based
barriers to care (Kassler, Tomoyasu, & Conway, 2015). An important finding (Bartels, Gill, &
Naslund, 2015) has shown that most older adults would like to receive mental health services
in a primary care setting instead of a traditional psychiatric setting because they will not be
stigmatized. Therefore, the coordinating functions of ACOs might be able to promote
integration between mental health and primary care, thus further improving behavioral health
conditions or outcomes (Bartels et al., 2015; Lewis, Colla, Tierney, Citters, Fisher, & Meara,
2014).
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Gaining savings and increasing market share. In order to sustain an ACO model,
accountable care organizations need to promise that their partners will gain net savings,
which in turn could make them more motivated to continue their participation (Perez, 2014).
A shared savings payment arrangement is a priority choice for hospitals participating or
planning to participate in an ACO (Audet et al., 2012). When an ACO uses an effective
coordination of care model to deliver patient services, providers reduce duplicated services.
Better coordination of care makes savings possible because patients’ expenditures are below
the benchmark and providers meet thirty-three quality measures (Yeung et al., 2011).
Larger ACOs have lower per-beneficiary initial costs than small ACOs, and ACOs
increases their market share (Larkin, 2014). From the hospitals’ perspective, if an ACO does
not generate shared savings, a positive net impact could still be possible because of increased
market share (Harris, Grauman, & Hemnani, 2010).
Challenges.
Investing in and experiencing incompatible information systems. ACOs make
progress using health information technology (IT) to improve care (Conn, 2015). Health
information technology becomes a necessary investment for providers to track patient
outcomes across settings (Yeung et al., 2011). Near-real-time information and data not only
help to improve an ACO’s quality of care, but also, near-real-time information aids in
tracking partners’ performance. Thus, it is imperative to have an information technology
system with the capacity for near-real-time data and feedback (Conn, 2015; Lowell & Bertko,
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2010). IT is an expected challenge in an ACO because there is a need to coordinate IT within
partners (Hunt et al., 2015). Most independent providers think that they cannot afford the
investment because they think the investment is too costly (Powell, Post, & Bishop, 2014).
The biggest challenge is investing on a system-wide basis and developing clinical and
management information systems even for hospitals planning to participate in an ACO(Audet
et al., 2012). Most of the time, IT platforms are not connected between local health systems
and independent providers. Furthermore, providers also need to overcome the technical
difficulties in reaching meaningful usage levels (Kutscher, 2014; Conrad, Grembowski,
Hernandez, Lau, & Marcus-Smith, 2014).
Concern about physician autonomy. Physicians typically enjoy great autonomy in
decision making. However, as referrals become a mechanism for controlling costs and
assuring quality in an ACO, physicians’ levels of autonomy are reduced. An example of an
ACO referral mechanism that limits physician autonomy is when the ACO distributes a list of
preferred providers for referrals and physicians must select on the basis of cost (DeCamp &
Lehmann, 2015).
ACO and Its Performance
Health care organizational performance can be influenced by relatively uncontrollable
factors to relatively controllable ones (Shortell & Kaluzny, 2006). Take factors affecting
outcomes of care, for example. Environmental characteristics belong in relatively
uncontrollable factors, such as regulation, legal forces, and natural disasters. Relatively
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controllable factors include inter-organizational and organizational characteristics, such as
network coordination issues, organization size, technology usage, and capital investment. In
order to have effective management, executives should focus on relatively controllable
factors.
Although the CMS is flexible enough to allow ACOs to adopt their own operation
models/tools, health care providers still like to know key determinants of success in ACOs.
Some studies discussed the possible institutional leadership models, such as a hospital-led
model, a primary care based model, and a physician-led ACO model (Shield et al., 2011;
Fisher, Staiger, Bynum & Gottlieb, 2007; Crosson, 2009; Wexler, Hefner, Welker, &
McAlearney, 2014; Phillips, Petterson, Teevan, & Pace, 2011; Mostashari, Sanghavi, &
McClellan, 2014), but little is known about which model has achieved the best performance
in the ACO operation.
A coordinated infrastructure and the key stakeholders’ engagement are treated as key
drivers of ACOs (Lowell & Bertko, 2010; Dadlez, 2014). For the coordinated infrastructure,
most studies put the emphasis on health information technology because it benefits
coordination of care, cost control, and accurate and timely data (Vedel, Akhlaghpour, Vaghefi,
Bergman, & Lapointe, 2013; Barnes, Unruh, Chukmaitov, & Ginneken, 2014; Perez, 2014;
Parker & Aronoff, 2015). Yeung and colleagues (2011) noted that physician engagement can
enhance successful clinical care in an ACO model. For instance, physicians become involved
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in everything from defining changes to how they deliver care to patients in an ACO (Zenty,
Bieber, & Hammack, 2014). When it comes to complex patients, specialist input cannot be
ignored in an ACO because specialists can provide high-value services to these patients
(Joynt, 2014).
In the era of health care reform, providers recognize the importance of patients’
commitment, but it is a huge challenge to get these beneficiaries engaged (Lee, 2014;
Hagland, 2014). Case management is one way to manage patients’ health (Stutz, 2011). Also,
the company Crystal Run noted that care manager programs can improve quality indicators of
patients at high risk (Spencer, 2014). However, it is still challenging to control patients'
compliance and home environment to improve ambulatory care quality and population health
(Zenty et al., 2014). Therefore, ACO models emphasize lifestyle management, and key
elements include prevention, risk reduction, and self-care. This lifestyle management team
consists of a physician, an exercise physiologist, a nurse, a behavioral counselor, a dietician,
and physical and occupational therapists, and together, they can design medical interventions
for promoting patients’ health status (Wexler et al., 2014; Arena & Lavie, 2015).
Synthesis of the Literature
In a short four-year period, the CMS Innovation Center has offered six different ACO
programs that can fit different health care providers’ demands when they join an ACO. The
designs of the six ACO programs have shown the intention of the CMS Innovation Center in
encouraging new ACOs to form and existing ACOs to move to high-risk tracks. Among the
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six CMS ACO programs, the MSSP ACO presents its incredible growth in size and the
number of Medicare beneficiaries served.

All these signs indicate the accountable care

programs are the trend in health care reform, especially the MSSP ACO.
Although several studies (Lewis et al., 2014; Yeung et al., 2011; Audet et al., 2012;
Powell et al., 2014; DeCamp & Lehmann, 2015) have explored the opportunities and
challenges of ACOs from a health care provider perspective, the requisite information needed
has yet to be integrated into an evidence-based approach in order to explain the variability in
diffusion of an ACO model’s formation. Thus, I used those studies to guide the development
of my questionnaire regarding the adopters’ attitudes and beliefs in an ACO model.
According to studies on the diffusion of innovations in health care, the value that individuals
place on innovation varies greatly between innovations, but perceived attributes by
individuals play a significant role in the adoption of an innovation. In Rogers’ (1995)
diffusion of innovation model, the important elements of innovation adoption include
innovation characteristics, communication channels, time, and the social system (context). In
other words, not only might individuals’ (or other decision-making units’) attitudes toward
innovation directly influence the adoption of innovation, the social system also affects this
adoption. Therefore, I found it necessary to add Duncan’s (1959) ecological complex model
to help explain how contextual factors contribute to social change and the diffusion of new
ideas associated with ACOs.
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In summary, for effective management, executives should focus on relatively
controllable factors affecting organizational performance, such as an institutional leadership
model and IT usage, which is what my research focuses on. My research focuses neither on
the intermediate degrees of control, such as key stakeholders’ engagement, nor on the
relatively uncontrollable factors such as poverty, unemployment, and marketing competition.
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CHPATER THREE THEORETICAL FRAMEWORK AND HYPOTHESES
Theoretical Framework
In Rogers’ (1995) diffusion of innovation theory, an innovation is defined as “an idea
perceived as new by an individual or other unit of adoption,” and diffusion is defined as “the
process by which an innovation is communicated through certain channels over time among
the members of a social system” (Rogers, 1995, p. 10-11). An individual’s (or other decisionmaking unit’s) decision-making about an innovation is a process, and the innovation-decision
process is “the process through which an individual (or other decision-making unit) passes
from first knowledge of an innovation [knowledge stage], to forming an attitude toward the
innovation [persuasion stage], to a decision of adoption or rejection [decision stage], to
implementation of the new idea [implementation stage], and finally to confirmation of this
decision [confirmation stage]” (Rogers, 1995, p. 163). The decision stage is the focal point of
my research. The five stages can be influenced through channels of communication over
time. Additionally, the characteristics of the decision-making unit can influence the
knowledge stage, such as socioeconomic characteristics, personality variables, and
communication behaviors. The persuasion stage can be impacted through that individuals’ (or
other decision-making unit’s) perception of five core characteristics of the innovation,
including relative advantage, compatibility, complexity, trialability, and observability.
Not only do individuals (or other decision-making units) directly influence the
adoption of innovation, the social system also affects this adoption (Shortell & Kaluzny,
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2006). Moreover, the social system also indirectly influences the adoption of innovation
through these individuals (or other decision-making units). Duncan’s (1959) ecological
complex model, or POET model, which includes population (P), organization (O),
environment (E) and technology (T), and all of which contribute to social change and the
diffusion of new ideas. The original POET model presents an interconnected relationship
between human populations, their technology, their social organizations, and their physical
environments in order to examine human societies (Duncan, Schnore & Rossi, 1959; Duncan,
1959). In this study, as the POET variables are considered as contextual factors in explaining
the social change, each of the four elements can directly and indirectly impact the adoption of
innovation.
In my research, ACOs’ performances, including the perceived and actual performances,
cover eight quality domains, and the perceived and actual performance was collected from
questionnaires and the CMS’s ACO dataset, respectively. Additionally, Shortell and Kaluzny
(2006) pointed out that outcomes of care are influenced by six domains: environmental,
interorganizational, organizational, and patient characteristics, unit characteristics and
processes, and provider characteristics and processes. In the health care field, an adoption of
an innovation is expected to improve an organization’s performances in terms of cost, quality,
or access. Moreover, organizational learning involves associating the adoption time with the
performance (Huber, 1991). Further, Jacobs and colleagues (2015) noted that adoption timing
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impacts an organization’s performance, especially for administrative innovations. However, it
is not yet known whether early adopters have good chances of success in improving the
organizations’ performances. My study assumes the performances of an ACO model could be
impacted by the contextual factors (POET variables) and the timing of the adoption of an
ACO model.
To conceptualize the framework, Figure 1 illustrates a theoretically integrated
framework using Rogers’ (1995) diffusion of innovation theory and Duncan’s (1959) POET
model to guide three major research aims of this study. Aim 1 is to explore the critical factors
influencing the timing of an ACO model adoption. Aims 2 and 3 are to examine ACO
executives’ perceptions of ACO model performance and the actual ACO model’s performance
that might be influenced by Duncan’s POET model and the timing of such an adoption,
respectively.
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Variables
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innovation
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Aim 1:
The length of
time as an ACO
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ACO models’
Performances

Technology
Variables

Figure 1 Theoretical framework using Rogers’ diffusion of innovation theory and Duncan’s
POET model
Based on the theoretical framework identified earlier, Figure 2 shows the eight initial
research hypotheses in visual ways, which are possible factors that contribute to the three
research aims. Aim 1 is to explore the critical factors influencing the timing of an ACO model
adoption. Aims 2 and 3 are to examine perception of ACO model performance and the actual
ACO model’s performance, respectively. The aims are to explore the critical factors
influencing: 1) the timing of the adoption of an ACO model, 2) the perception of ACO model
performance, and 3) the actual ACO model’s performance. The research framework consists
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of one latent variable (the actual ACO performance with eight indicators) and eleven
indicators, and the eight initial research hypotheses are described by aims in the following
section.

H1a
Organizational variables
Institutional leadership model

Timing of the
adoption of an ACO
model
H2c

H1b
H2a

Technology variables
1.
2.
3.

Functionalities
Usage levels
Integration levels

H2b

H3a
Rogers’ five core
characteristics of innovation
1.
2.
3.
4.
5.

Perception of ACO
model performance

H3b

H1c

Actual
ACO model’s
performance

Relative advantage
Compatibility
Complexity
Trialability
Observability

Figure 2 Formulation of a research framework: the diffusion and performance of the
accountable care organization model.
Hypotheses of Aim 1: Timing of the Adoption of an ACO Model
Characteristics of the contextual factors: Hypothesis H1a – H1b. Previous studies in
the health care field found the common predictors of innovation adoption in the population,
organization, environment, and technology levels. The population variables include
unemployment and poverty rate. Higher unemployment and poverty rates decreased the
likelihood of electronic medical records adoption (Menachemi, Mazurenko, Swanson Kazley,
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Diana, & Ford, 2012). In nursing homes, a higher average income in the country increased
the likelihood of early innovation adoption (Castle, 2001).
Hikmet and colleagues (2008) found organizational factors explained 37.4% adoption
variance in health care information technology (IT). The essential organizational variables
included size (economies of scale), non-profit ownership, and system affiliated hospitals (or
chain memberships) (Kimberly & Evanisko, 1981; Castle, 2001; Bhuyan et al., 2015; Hikmet
et al., 2008; Furukawa, Raghu, Spaulding, & Vinze, 2008; Kazley & Ozcan, 2007; Lin, Lin,
Roan, & Yeh, 2012). My study showed that the number of beneficiaries can demonstrate
ACOs’ economies of scale, and the hospital-based network affiliation model implies the
advantage of capacity.
The environmental variables include competition and age of organization. A more
competitive environment increased the likelihood of early innovation adoption in nursing
homes (Castle, 2001). Kimberly and Evanisko (1981) found that the age of the organizations
was the most significant positive influence on hospital adoption of administrative innovations
among environmental variables.
For complex innovation in health services, when a technology includes a key
functionality and works efficiently, it helps make the innovation adoption successful and
widely adopted (Greenhalgh et al., 2008). Also, IT usage levels indicate whether health care
providers deliver the best coordinated care. For instance, if a health care provider shares only
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basic electronic data across providers, the meaningful usage of coordinated care is not
optimal (McClellan et al., 2014). Therefore, it is imperative to collect ACOs’ IT
functionalities, usage levels, and the integration levels in a well-designed questionnaire.
In my research, the ACO model adoption might be affected by contextual variables
other than Rogers’ (1995) five core characteristics of innovation. According to previous study
findings (Menachemi et al., 2012; Castle, 2001; Kimberly & Evanisko, 1981in the adoption
of innovation in the health care field, most of the contextual variables were treated as
controlled variables in the research framework. In my study, only the hospital-based network
affiliation and the degree of information technology are predictor variables in the following
two hypotheses.
H1a: The hospital-based network affiliation model adopts an ACO model earlier than
the physician-led model.
H1b: Organizations with a higher degree of information technology are more likely to
be identified as an early adopter of the innovation related to ACO.
Rogers’ (1995) five core characteristics of innovation as explanatory factors:
Hypothesis H1c. In the health care industry, adopters’ attitudes and beliefs regarding the
adoption of innovation can explain the adoption speed (Loomis et al., 2002; Lin et al., 2012;
Castillo, Martinez-Garcia, & Pulido, 2010). Different stakeholder groups have different
perceptions toward the adoption of innovation, so challenges within each stakeholder group
should be specifically targeted (Patel & Antonarakis, 2012). My research assumes that
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executives of ACOs are the main stakeholders in the decision-making stage of an ACO model
adoption, so my survey was distributed to these executives. Among Rogers’ (1995) five
characteristics of innovation, the most important factor is a high compatibility attribute, and
the other factors are equal to each other in affecting innovation adoption (Alkraiji et al., 2013;
Sams et al., 2013; Peeters et al., 2012; Hsu et al., 2013; Morton & Wiedenbeck, 2009;
Spaulding et al., 2005; Chew et al., 2004; Pronk et al., 2002). Therefore, in my study, the five
characteristics of innovation were aggregated to the adopters’ attitudes and beliefs regarding
the adoption of innovation, and these characteristics also affected executives’ adoption of an
ACO model. Thus, hypothesis H1c is as follows:
H1c: Executives valuing the ACO model are more likely to adopt an ACO earlier.
Hypotheses of Aim 2 and Aim 3: ACO Model’s Performance
As of October 2014, the CMS had posted MSSP ACO performance year 2013 and 2014
results on the official public website for Data.CMS.gov. In other words, ACOs with a 2012 or
2013 agreement start dates reported two years’ performance results, and ACOs with a 2014
agreement start date started to report their first year performance results. In order to explore
the performances of all national 432 MSSP ACOs, this study did not emphasize only the
objective assessment of performance (the actual ACO model’s performance) , but also the
subjective one (the perception of ACO model performance).
Organizational leaders have been interested in these directly controllable factors by
them, such as capital investment strategy and salary administration, in trying to create high
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performing health care organizations. The spectrum of factors affecting health care
organizational performance showed that some of the factors are not directly controllable by
managers, such as environmental characteristics; and some factors can be relatively
controllable for managers, such as capital investment strategies and network coordination
issues (Shortell & Kaluzny, 2006).
The Centers for Medicare & Medicaid Services do not limit which models or tools
ACOs should use to achieve cost reduction and improve quality care, so providers have an
opportunity to explore innovative approaches in their respective types of Medicare ACOs
(Perez, 2014). In addition, the core value of an accountable care model is delivering
coordinated care at low cost, and this model is not limited to beneficiaries who can only
receive health care services within partners of an ACO network. Knowing this, a successful
ACO model would be determined by financial and clinical integration within an ACO
network as well as change in physician behavior and patient engagement. My research
focused on relatively controllable factors affecting the performance of an ACO model, and
these factors are institutional leadership models, information infrastructure’s functionalities
and usage levels, and the timing of becoming an ACO.
Institutional leadership models. There is not a golden standard for classifying ACO
operation types because ACOs are in the modeling stage. Audet et al., (2012) noted three
major types of models in the market: Physicians and Hospitals, Physician-led Governance,
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and Hospital-led Governance. Another study suggested similar categories for identifying
three institutional leadership models in ACOs: Physician-led ACO, Integrated Delivery
System (IDS) ACO, and Hybrid ACO (Shortell et al., 2014). However, which ACO model
will be the best development for ACOs is still yet to be confirmed (Dove,Weaver, & Lewin,
2009).
Little is known, however, with regard to the types of institutional leadership models
that have achieved the best performance in an ACO operation. Some studies have explored
the advantages of a specific ACO model, but no clear evidence shows a competitive
advantage for any specific ACO model. However, Fisher et al. (2007) reported that the
advantage of an integrated model between a local acute care hospital and physicians is the
creation of accountable care for patients. For instance, when health care providers reach
economies of scale in size, they often have the ability to invest in support and technical
systems. Well-known examples of successful physician-hospital integration are Kaiser
Permanente, Mayo Clinic, and Geisinger Health System (Crosson, 2009). However, mature
physician leadership becomes the essential driver in health care reform. According to a
national survey of ACOs between October 2012 and May 2013, 51% of ACOs were the
physician-led model, and this model has better monitoring and reporting capabilities than the
other ACOs (Colla, Lewis, Shortell, & Fisher, 2014). In ACO subgroups, independent
primary care groups showed greater savings than hospital-integrated groups (McWilliams et
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al., 2016). Mostashari and colleagues (2014) pointed out that physician-led ACOs have a
much larger reduction of health care costs than did hospital-based ACOs because these
hospital-based ACOs’ cost reduction methods, such as avoiding hospitalizations or shifting
care to a less costly ambulatory setting, are lost revenue for hospitals. However, no savings
difference was found between ACOs with or without clear financial integration within
hospitals and physician groups (McWilliams et al., 2015).
Primary care is central in ACOs, and a primary care-based ACO is considered a
potential model for achieving improvement in patient outcomes and population health, and
reducing the per capita cost of care (Wexler et al., 2014). A primary care-based ACO model
can have good performances in providing preventive services and a low adjusted mortality
rate (Phillips et al, 2011). Although the case study of this model does not affiliate with a
hospital or most specialists, this primary care-based ACO model includes critical features for
operating successfully, such as disease management, onsite pharmacies, care coordination
and transportation, and technology to support continuous care.
In summary, an organization’s long-term success might be determined by the ability of
ACOs to meet the behavioral health needs of their patients (Lewis et al., 2014). The ability
for success for ACOs is based on understanding the environmental context, building robust
governance structures, aligning system design with value-based principles, and using
measures to improve organizational performance (Kotzbauer & Weeks, 2014). The hospital37

based network affiliation model might implicate other key elements of success in an ACO,
such as a sufficient patient population size, integration experiences within the delivery
system, and the capacity of collecting and reporting on the performance of participating
providers (Lowell & Bertko, 2010). Thus, my research the research assumes that
organizations utilizing the hospital-based network affiliation model to operate ACOs have
better performance than other types.
Information infrastructure’s functionalities and usage levels. Health IT has a
positive influence on clinical process, such as increased quality of care, continuity, timely
access, improved uptake of preventive care, assessment and monitoring, and decreased error
(Vedel et al., 2013). IT makes coordination of care possible. A patient-centered and integrated
care-oriented IT structure can help an ACO effectively control costs and improve population
health (Barnes et al., 2014). Baloh et al. (2014) also noted that the use of electronic health
record systems fostered core ACO capabilities in rural areas. A data-driven approach in an
ACO leads to high-performance through analyzing data, such as identifying gaps in care, so it
is necessary to use accurate and timely information to analyze data (Perez, 2014; Parker &
Aronoff, 2015). In addition, tracking quantitative outcomes can support value-based health
care delivery because data analytics can perform accurate risk assessment on an ACO’s
beneficiaries (Batson & Batson, 2015; Hagland, 2014). Because the usages and
functionalities of IT could vary greatly from organization to organization, the description of
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an organization’s data systems and data capability is essential information within an ACO
(Quinn, 2014). In summary, my research assumes organizations with a high degree of IT
(sophistication of IT systems in place) have better performance.
Timing of the adoption of an ACO model. Technical and organizational innovations
are common in the health care field. An ACO model is a mixed innovation because the ACO
concept includes ideas for new clinical processes and organizational structures. In order to
respond to uncertainty, organizations tend to model themselves after similar organizations
that they perceive to be more legitimate or successful in their fields (DiMaggio & Powell,
1983). The time element in the diffusion of innovation indicate the different adopter types,
such as early adopter and later adopter (Rogers, 1995). From the organizational learning
perspective, late adopters most likely would have better performance than early adopters
because late adopters can benefit from knowledge acquisition, information distribution,
information interpretation, and organizational memory (Huber, 1991). However, late
adopters’ performance is moderated by certain environmental and organizational structure
factors (Jacobs et al., 2015).
For these reasons, the hypotheses for the perception of ACO model performance (Aim
2) and the actual ACO models’ performance (Aim 3) are stated as H2a through H2c and H3a
through H3b, respectively. Although MSSP ACO public reports are freely accessible from
their individual websites, ACO public reports did not provide information on the
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sophistication of agencies’ information technologies. The degree of information technology
was collected by a survey conducted through my research. Thus, research aim 2, using a
survey dataset, exhibits three hypotheses. Research aim 3, using a year-one performance
dataset, presents only two hypotheses.
H2a: Among those adopting the hospital-based network affiliation model, their
executives’ perceptions of performance are higher than the physician-led model.
H2b: Among those organizations with a higher degree of information technology, their
executives have higher perceptions of performance.
H2c: Late adopters have higher perceptions of performance than early adopters.
H3a: Among those adopting the hospital-based network affiliation model, their actual
performances are higher than the physician-led ACO model.
H3b: Late adopters have higher actual ACO performances than early adopters.
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CHAPTER FOUR METHODS
Study Design
This study was a cross-sectional design utilizing a survey supplemented by secondary
data with the analysis unit at the organization’s level. The end date of the study was
December 31, 2015. A mail survey was distributed to MSSP ACO executives in October
2015. The secondary data included the list of Medicare Shared Savings Program ACOs;
MSSP ACO public reports; performance year-one results for MSSP ACO with 2012, 2013,
and 2014 start dates; and the 2013-2014 Area Health Resource File (AHRF). The ACO
Taxpayer Identification Number (TIN) name was the unique key identifier between the
survey and secondary datasets. For the AHRF database, a state code was a unique key
variable used to identify county level information, such as the poverty rate, unemployment
rate, and market competition score.
Study Participants
ACOs are organized by groups of doctors, hospitals, and/or other health care providers,
who come together voluntarily to provide coordinated high quality care to their Medicare
patients (CMS, 2013b). The MSSP ACOs were the participants in this study, and their service
subjects were the fee-for-service beneficiaries. The following presents a detailed description
of study participants for each research aim.
Study participants for research aim 1 & 2. The MSSP ACOs with contractual
agreements with CMS in 2012, 2013, 2014, or 2015 were qualified participants in this study
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for research aim 1 and aim 2. There are two sources to access the MSSP ACOs mailing list
from the Centers for Medicare and Medicaid Services website. The first source is a
searchable list of MSSP ACOs, and the other one is a MSSP initial enrollment list. In order to
maximize the size of MSSP ACOs, I used both data sources to create a comprehensive
mailing list. The final number of ACOs on the mailing list included 447 MSSP ACOs. MSSP
ACO executives or managers were the survey respondents.
In the review of prior survey research, there were two ACO studies conducted a survey.
One used an email survey design that asked specific questions about physicians’ likelihood of
joining an ACO in Alabama. Its response rate was only 5% (Powell et al., 2014). Another
study had a higher response rate at 81% among MSSP ACOs. Additionally, in the same
study, 98% of the respondents completed the survey online, and the other 2% completed the
survey on the telephone (Colla et al.,2014). Therefore, a 50% of response rate would be a
reasonable goal for my survey. The survey process used the Dillman Tailored standard survey
method (Salant & Dillman, 1994), and I sent a follow-up reminder E-mail after the initial
survey. When the response rate of the first mailing was lower than the pre-set target at 50%, a
calling campaign was conducted to non-respondents of the mailed survey to maximize the
response rate.
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Study participants for research aim 3. MSSP ACOs that had year-one performance
records were the qualified participants for research aim 3. By the end of 2015, a total of 348
MSSP ACOs with 2012, 2013, and 2014 start dates had their year-one performance results.
Data Sources
Five datasets were used in this study. Table 3 shows the data sources, how to gain
access to the study variables, and their corresponding variables.
The first source of data came from the primary survey was conducted by this study. A
structured survey was based on Rogers’ (1995) diffusion of innovation theory. The main
purpose of this survey was to understand how ACO executives evaluated the characteristics
of the ACO model and their perceptions of performance. The survey items included the
length of time as an ACO [Q1], the characteristics of the ACO model [Q5 – Q8], organization
variables [Q9 – Q11], technology variables [Q12 –Q16], and the perceptions of ACO
performance held by each individual ACO executive or manger [Q17]. The detailed
questionnaire is provided in Appendix A.
The second data source was the MSSP ACO list, which included the ACO name,
physical address, service areas, ACO executive name and contact information, and the
representative’s contact name and information. For this study, the survey distributing list and
contact information were collected through a MSSP ACO initial enrollment list and a
searchable list of MSSP ACOs. The MSSP ACO initial enrollment for each cycle list was
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free and downloadable from the homepage for the News and Updates for Shared Savings
Program on the CMS website. The searchable list of MSSP ACOs was accessible without any
cost from the public ACO datasets on the CMS website. A total of 447 MSSP ACOs with
2012, 2013, 2014, and 2015 start dates were included in this survey distribution list.
The third data source was the MSSP ACO public reports, including ACO name, ACO
primary contact information, the composition of ACO, ACO participants, and quality
performance results. The public reports were downloaded from each individual ACO website.
This dataset supplemented the necessary information to define the institutional leadership
model using the composition of ACO.
The fourth data source was year-one performance results for MSSP ACOs with 2012,
2013, and 2014 start dates, including an ACO model’s basic information, such as the agreed
starting date and total assigned Medicare beneficiaries, generated savings/losses, earned
shared savings payments/owe losses, and 33 ACO performance indicators. This data was
downloaded from the CMS website. For this study, each ACO gained their own quality points
for each quality indicator based on the 2014 MSSP quality performance benchmarks and their
performance levels. Among 33 ACO indicators, 25 individual indicators and 2 composite
indicators have benchmark data. The range of quality points for each indicator is from 0 to 2,
so the maximum quality score for the 27 ACO indicators was 54 points in my study. For
more detailed information about this dataset, please see Appendix C. The 33 indicators were
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categorized into eight domains: the satisfaction of patient/caregiver experience [ACO#1 –
ACO#6, point range: 0 - 12 ], the quality of care coordination/patient safety [ACO#8 –
ACO#13, point range: 0 - 12], the potential beneficiaries coverage of preventive health
services [ACO#14 – ACO#21, point range: 0 - 16], and the quality of care of the potential
beneficiaries of an at-risk population including diabetes [composite ACO#22-26 and
ACO#27, point range: 0 - 4], hypertension [ACO#28, point range: 0 - 2], ischemic vascular
disease [ACO#29 – ACO#30, point range: 0 - 4], heart failure [ACO#31, point range: 0 - 2],
and coronary artery disease [composite ACO#32–33, point range: 0 - 2].
The fifth data source was the area health resources files (AHRF), a county-level
database. It is comprised of health care professionals, hospitals and health care facilities,
census data, population data, and environmental/contextual indicators. The AHRF was made
available at no cost by Health Resources and Services Administration (HRSA). For this
study, two variables from the AHRF were used: the poverty rates in 2012 and 2013 and
unemployment rates in 2012, 2013, and 2014. These variables constituted the contextual
factors that portray the area characteristics of an ACO.
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Table 3 Data Sources and the Corresponding Variables in This Study
Data set

Source

Access Website

Corresponding variable

1. Survey

Conducted by this study

N/A

See Appendix A

2. The list of

1. Centers for Medicare &

Data.CMS.gov

1. ACO name

Medicare

Medicaid Services

2. Physical address

shared savings

2. Updated semi-annually

3. ACO service areas

program ACOs

3. Updated January 2015

4. ACO executive name
and contact information
5. Public contact name and
contact information

3. MSSP ACO

Individual ACO’s website

N/A

public report

1. ACO name
2. ACO primary contact
information
3. Composition of ACO
4. ACO participants
5. Quality performance
results

4. MSSP ACOs
performance

Centers for Medicare &

Data.CMS.gov

Medicaid Services

1. ACO name
2. Agreement start date

year-one results

3. Total assigned

(for ACOs with

Medicare beneficiaries

2012, 2013, and

4. 33 ACO performance

2014 start

indicators

dates)
5. 2013-2014 Area
Health

Health Resources and

http://ahrf.hrsa.gov/

Services Administration

1. Poverty rate in 2012
and 2013
2. Unemployment rate in

Resources Files

2012, 2013, and 2014

(AHRF)
Note:
N/A: not applicable
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Measurement of the Variables
The dependent variable (or an endogenous latent variable), primary predictors, and
control variables were described for each of the three research aims. The first aim was to
examine the timing of adoption of an ACO model. The second and third aims were to
examine the perception of ACO model performance and the actual ACO model performance,
respectively. The operational definition and measurement instruments for research aim 1, aim
2, and aim 3 are listed in Table 4, Table 5, and Table 6, respectively.
Aim 1: What are the relative influences of contextual variables and ACO characteristic
variables on how early an ACO model was adopted?
H1a: The hospital-based network affiliation model adopts an ACO model
earlier than the physician-led model.
H1b: Organizations with a higher degree of information technology use are
more likely to be identified as an early adopter of the innovation related to
ACO.
H1c:

Executives valuing the ACO model are more likely to adopt an ACO
earlier.

Dependent variable. The length of time was an ACO data point to measure how early
an ACO model was adopted, and that was measured in months of adoption. The length of
time as an ACO was calculated by the agreement start date and the end date of this study. For
this study, the earliest MSSP agreement starting date was April 1, 2012, and most recent one
was January 1, 2015. The end date of this study was December 31, 2015. In other words, the
range of the length of time as an ACO was from 12 months to 42 months. Since the length of
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time as an ACO was no more than 24 months, all of these were categorized as late ACO
adopters. The length of time as an early ACO adopter was greater than 24 months.
Predictor variables. There were three predictor variables in research aim 1:
institutional leadership model, a degree of information technology (IT), and Rogers’ (1995)
innovation characteristics. The three predictor variables were composite variables which were
drawn from the survey results. The types of institutional leadership models were collected
from an email survey (Q9, see Appendix A). If the composition of an ACO was a medical
practice group, network of individual practice, or physician network, its institutional
leadership model was assigned as physician-led ACO. If the composition of an ACO was a
hospital system(s) based, integrated delivery system, or a partnership of hospital system(s)
and medical practices, its institutional leadership was assigned as hospital-based ACO.
A degree of IT use (sophistication of IT systems in place) contained the information
collection method, the status of EMRs, the IT functionalities, the IT usage levels, and the
integration levels. All five variables were collected through the email survey. The information
collection method was measured by the types of information collected by an ACO. The status
of EMRs was measured by the percentage of an ACO’s partners having an EMR system. A
four-point Likert scale from not implemented (0 points) to fully implemented (4 points) was
utilized to measure the information infrastructure’s functionalities, usage levels, and the
integration levels at two different time periods (currently and ACO agreement start date). The
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maximum score for each of the information infrastructure’s functionalities (including 5 subquestions), usage levels (including 5 sub-questions), and the integration levels (including 5
sub-questions) was a total of 20 points. In order to compare each of the total scores among
information infrastructure’s functionalities, usage levels, and integration levels, all point
scores were converted into a 0 to100 scale.
The positive values of ACO characteristics were measured by executives who have
greater relative advantage, compatibility, trialability, observability, and less complexity.
Trialability is the degree to which an innovation may be experimented with on a limited
basis. These variables were measured by a 5-point Likert scale from strongly disagree (0
points) to strongly agree (5 points) through the email survey. The score range for the ACOs’
advantages (including 5 sub-questions) was from 0 to 25 points. The score range for the
ACOs’ compatibility (including 4 sub-questions) was from 0 to 20 points. The score range for
the ACOs’ trialability (including 1question) was from 0 to 5 points. The score range for the
observability of ACOs’ results (including 5 sub-questions) was from 0 to 25 points. The score
range for the ACOs’ complexity (including 6 sub-questions) was from 0 to 30 points; a lower
score showed a higher level of complexity. In order to compare each of the total scores in
ACOs’ advantages, compatibility, trialability, complexity, and the observability of ACOs’
results, all point scores were converted into a 0 to 100 scale.
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Control variables. The contextual variables consisted of population, organizational,
and environmental variables. The population variables included unemployment rates and the
poverty rates at the county level. The organizational variable included the total number of
assigned Medicare beneficiaries, and this variable was collected from the email survey (Q10,
see Appendix A). The environmental variable included market competition scores
(Herfindah-Hirschman Index, or HHI), and HHI range was from zero to one. A lower HHI
indicated a higher competitive index. The number of Medicare served by ACOs was accessed
at the state level. I calculated the market competition scores by taking the market share of the
respective ACO competitors at the state level, squaring it, and adding them together. The
ACO market share at the state level was calculated as a total number of assigned Medicare
beneficiaries divided by the total number of Medicare beneficiaries in a state.
Aim 2: How is the perception of ACO performance influenced by the contextual
variables, ACO characteristic variables, and timing of the adoption of an ACO
model?
H2a: Among those adopting the hospital-based network affiliation model,
their executives’ perceptions of performance are higher than the
physician-led model.
H2b: Among those organizations with a higher degree of information
technology, their executives have higher perceptions of performance.
H2c: Late adopters have higher perceptions of performance than early
adopters.
Dependent variable. Each ACO had to meet the quality of ACO performance
standards in order to share in any savings generated. The CMS proposed 33 quality
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indicators, which were categorized into eight domains: the satisfaction of patient/caregiver
experience, the quality of care coordination/patient safety, the potential beneficiaries,
coverage of preventive health services, and the quality of care of the potential beneficiaries of
these at-risk populations: diabetes, hypertension, ischemic vascular disease, heart failure, and
coronary artery disease.
This study assumed that executives/ high-level managers of ACOs ranked the eight
domains as a high priority in operating ACOs. This study also assumed that their perceptions
of ACO performance in eight domains should be more reliable than others in these
organizations. Therefore, the perception of ACO performance held by individual ACO
executives was measured by the eight domains through the email survey, using Qualtrics.
These eight variables were measured using an interval scale (ranging from 0 to 100); higher
scores indicated higher perceptions. The overall perception of ACO performance was an
average score of the eight ACO quality domains.
Predictor variables. There were three predictor variables in research aim 2:
institutional leadership model, a degree of IT use (sophistication of IT systems in place), and
the length of time as an ACO. The first two predictor variables were composite variables
which were drawn from the survey results. The types of institutional leadership models were
collected from the email survey (Q9, see Appendix A). If the composition of an ACO is a
medical practice group, network of individual practice, or physician network, its institutional
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leadership model was assigned as physician-led ACO. If the composition of an ACO was
hospital system(s) based, an integrated delivery system, or a partnership of hospital system(s)
and medical practices, its institutional leadership was assigned as hospital-based ACO.
A degree of IT use (sophistication of IT systems in place) contains the information
collection method, the status of EMRs, the IT functionalities, the IT usage levels, and the
integration levels. All of these five variables were collected through the email survey. The
information collection method was measured by the types of information collected by an
ACO. The status of EMRs was measured by the percentage of the ACO’s partners that have
an EMR system. A 4-point Likert scale from not implemented (0 points) to fully implemented
(4 points) was utilized to measure the information infrastructure’s functionalities, usage
levels, and the integration levels at two different time periods (current and ACO agreement
start date). The maximum score for each of the information infrastructure’s functionalities
(including 5 sub-questions), usage levels (including 5 sub-questions), and the integration
levels (including 5 sub-questions) was a total of 20 points. In order to compare each of the
total scores among the information infrastructure’s functionalities, usage levels, and the
integration levels, all point scores were converted into a 0 to 100 scale.
The length of time as an ACO was utilized to measure how early an ACO model was
adopted in the email survey, and that was measured in months of adoption. As the length of
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time as an ACO was no more than 24 months, they all belonged to the category of late ACO
adopters. The length of time as an early ACO adopter was greater than 24 months.
Control variables. The control variables in research aim 2 included the contextual
variables and Rogers’ (1995) innovation characteristics. The contextual variables include
population, organizational, and environmental. The population variables included
unemployment rates and the poverty rates at the county level. The organizational variable
included the total number of assigned Medicare beneficiaries, and this variable was collected
from my email survey (Q10, see Appendix A). The environmental variable included market
competition scores (Herfindah-Hirschman Index, or HHI), and HHI range was from zero to
one. A lower HHI indicated a higher competitive index. The number of Medicare served by
ACOs was accessed at the state level. I calculated the market competition scores by taking
the market share of the respective ACO competitors at the state level, squaring it, and adding
them together. An ACO market share at the state level was calculated as a total number of
assigned Medicare beneficiaries divided by the total number of Medicare beneficiaries in a
state.
The positive values of ACO characteristics are measured by executives who have
greater relative advantage, compatibility, trialability, observability, and less complexity.
Trialability is the degree to which an innovation may be experimented with on a limited
basis. These variables were measured by a 5-point Likert scale from strongly disagree (0
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points) to strongly agree (5 points) through my email survey. The score range for the ACOs’
advantages (including 5 sub-questions) was from 0 to 25 points. The score range for the
ACOs’ compatibility (including 4 sub-questions) was from 0 to 20 points. The score range for
the ACOs’ trialability (including 1question) was from 0 to 5 points. The score range for the
observability of ACOs’ results (including 5 sub-questions) was from 0 to 25 points. The score
range for the ACOs’ complexity (including 6 sub-questions) was from 0 to 30 points, and a
lower score showed higher complexity. In order to compare each of total scores in ACOs’
advantages, compatibility, trialability, complexity, and the observability of ACOs’ results, all
points were converted to an interval scale (ranging from 0 to 100).

Aim3: How is the actual ACO performance influenced by the contextual variables,
ACO characteristic variables, and timing of the adoption of an ACO model?
H3a: Among those adopting the hospital-based network affiliation model,
their actual performances are higher than the physician-led ACO
model.
H3b: The late adopters have higher actual ACO performances than the early
adopters.
Endogenous observed variable. In the Medical Shared Saving Program (MSSP), it is
imperative for ACOs to report quality data in order to share in any savings generated. The
actual ACO performance included 33 indicators that were categorized into eight domains: the
satisfaction of patient/caregiver experience [ACO#1 – ACO#7], the quality of care
coordination/patient safety [ACO#8 – ACO#13], the potential beneficiaries’ coverage of
preventive health services [ACO#14 – ACO#21], and the quality of care of the potential
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beneficiaries of these at-risk populations: diabetes [composite ACO#22-26 and ACO#27],
hypertension [ACO#28], ischemic vascular disease[ACO#29 – ACO#30], heart failure
[ACO#31], and coronary artery disease [composite ACO#32–33]. In this study, these
variables were accessed from the MSSP ACOs’ year-one performance results.
Most of the eight domains had more than one indicator. In this study, if indicators of
each domain have more than one indicator, they were aggregated into the same domain in
order to demonstrate its construct validity. The range of quality points for each indicator was
from 0 to 2, so the maximum quality score for the 27 ACO indicators was 54 points. Detailed
calculation information is presented in Appendix C.
Predictor variables. There were two predictor variables in research aim 3: institutional
leadership model and the length of time as an ACO. The institutional leadership model was a
composite variable which was collected from MSSP ACO public reports. If an ACO’s
composition had ACO professionals in group practice arrangements or networks of individual
practices of ACO professionals, its institutional leadership model was assigned as physicianled ACO. If an ACO’s composition had partnerships/joint ventures arrangements between
hospitals and ACO professionals, hospitals employing ACO professionals, or an integrated
delivery system/health system, its institutional leadership model was assigned as hospitalbased ACO.
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The length of time as an ACO was accessible in the MSSP ACO year-one performance
results dataset, and this variable was measured in months. The length of time as an ACO was
calculated by the agreement start date and the end date of this study. In this dataset, the
earliest MSSP agreement starting date was April 1, 2012, and the latest one was January 1,
2014. The end date of this study was December 31, 2015. In other words, the range of the
length of time as an ACO was from 24 months to 42 months.
Control variables. The control variables in research aim 3 were the contextual
variables. The contextual variables included population, organizational, and environmental.
The population variables included unemployment rates and poverty rates at the county level.
The organizational variable included the total number of assigned Medicare beneficiaries, and
this variable was collected from the MSSP ACOs year-one performance results. The
environmental/contextual variable included market competition scores (Herfindah-Hirschman
Index, or HHI), and the HHI range was from zero to one. A lower HHI indicated a higher
competitive index. The number of Medicare served by ACOs was accessed at the state level. I
calculated market competition scores by taking the market share of the respective ACO
competitors at the state level, squaring it, and adding them together. An ACO market share in
the state level was calculated as a total number of assigned Medicare beneficiaries divided by
the total number of Medicare beneficiaries in that state.
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Table 4 Operational Definition for Research Aim 1
Role

Variable

Timing of Adoption

Timing of adoption of an ACO
model

Population

Unemployment rate

Population

Variable Type
Independent
Dependent

Control

Scale

Data Source

Nominal

Questionnaire

X

Ratio

AHRF

Poverty rate

X

Ratio

AHRF

Organization

The number of assigned Medicare
beneficiaries

X

Interval

Questionnaire

Organization

Institutional leadership model

Nominal

Questionnaire & MSSP
ACO public reports

Environment

Market competition score

Ratio

Created by this research

Technology

Type of information collection

X

Interval

Questionnaire

Technology

The status of EMRs

X

Interval

Questionnaire

Technology

Information infrastructure’s
functionalities

X

Interval

Questionnaire

Technology

Information infrastructure’s usage
levels

X

Interval

Questionnaire

Technology

Integration levels

X

Interval

Questionnaire

Diffusion of Innovation

Relative advantage

X

Interval

Questionnaire

Diffusion of Innovation

Compatibility

X

Interval

Questionnaire

Diffusion of Innovation

Complexity

X

Interval

Questionnaire

Diffusion of Innovation

Trialability

X

Interval

Questionnaire

Diffusion of Innovation

Observability

X

Interval

Questionnaire

X

X
X
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Table 5 Operational Definition for Research Aim 2
Role

Variable

Perception of Performance

Perception of ACO model performance

Timing of Adoption

Timing of adoption of an ACO model

Population

Unemployment rate

Population

Variable Type
Independent
Dependent

Control

Scale

Data Source

Interval

Questionnaire; An average
of eight ACO quality
domains

Nominal

Questionnaire

X

Ratio

AHRF

Poverty rate

X

Ratio

AHRF

Organization

The number of assigned Medicare
beneficiaries

X

Interval

Questionnaire

Organization

Institutional leadership model

Nominal

Questionnaire & MSSP
ACO public report

Environment

Market competition score

Ratio

Created by this research

Technology

Type of information collection

X

Interval

Questionnaire

Technology

The status of EMRs

X

Interval

Questionnaire

Technology

Information infrastructure’s
functionalities

X

Interval

Questionnaire

Technology

Information infrastructure’s usage
levels

X

Interval

Questionnaire

Technology

Integration levels

X

Interval

Questionnaire

Diffusion of Innovation

Relative advantage

X

Interval

Questionnaire

Diffusion of Innovation

Compatibility

X

Interval

Questionnaire

Diffusion of Innovation

Complexity

X

Interval

Questionnaire

Diffusion of Innovation

Trialability

X

Interval

Questionnaire

Diffusion of Innovation

Observability

X

Interval

Questionnaire

X

X

X
X
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Table 6 Operational Definitions and Measurement Instruments for Research Aim 3
Variable Type
Role

Variable

Actual
Performance
Actual
Performance

Actual ACO model
Performance

Actual
Performance
Actual
Performance
Actual
Performance
Actual
Performance
Actual
Performance
Actual
Performance
Actual
Performance
Timing of
Adoption

Latent
Exogenous Endogenous

Observed
Exogenous Endogenous

Control

Scale

Data Source

X

Satisfaction (AP1)

X

Ratio

MSSP ACOs’ year-one
performance

Coordination and patient
safety (AP2)

X

Ratio

MSSP ACOs’ year-one
performance

Preventive health service
(AP3)

X

Ratio

MSSP ACOs’ year-one
performance

At-risk population: diabetes
(AP4)

X

Ratio

MSSP ACOs’ year-one
performance

At-risk population:
hypertension (AP5)

X

Ratio

MSSP ACOs’ year-one
performance

At-risk population: ischemic
vascular disease (AP6)

X

Ratio

MSSP ACOs’ year-one
performance

At-risk population: heart
failure (AP7)

X

Ratio

MSSP ACOs’ year-one
performance

At-risk population: coronary
artery disease (AP8)

X

Ratio

MSSP ACOs’ year-one
performance

Timing of adoption of an ACO
model

X

Ratio

MSSP ACOs’ year-one
performance
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Variable Type
Role

Variable

Scale

Data Source

Population

Unemployment rate (P1)

X

X

Ratio

AHRF

Population

Poverty rate (P2)

X

X

Ratio

AHRF

Organization

The number of assigned
Medicare beneficiaries (O1)

X

X

Ratio

MSSP ACOs’ yearone performance

Organization

Institutional leadership model
(O2)

X

Nominal

MSSP ACO public
report

Environment

Marketing competition score
(E1)

X

Ratio

Created by this
research

Latent
Exogenous Endogenous

Observed
Exogenous Endogenous
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Control

X

Data Analysis
For research aim 1 and aim 2, descriptive analysis was used to understand respondent
characteristics, which were collected in my survey. T test and chi-square analysis were used
to examine differences between early ACO and late ACO adopters. The research used
binomial logistic regression to examine the effects of POET and Rogers’ five core
characteristics in the early adoption of an ACO model (dichotomous). Pearson correlation
analysis was used to examine the correlation of the POET variables, the degree of IT
(sophistication of IT systems in place), and the perceptions of organizational effectiveness
among the MSSP ACOs. Also, I used multiple linear regression analysis to examine the
effects of POET and the timing of adoption of an ACO model for the perceptions of ACO
performance. In the binomial logistic regression and the multiple linear regression, timing of
adoption of an ACO model was treated as a nominal variable: early and late ACO adopters.

In research aim 3, confirmatory factor analysis and structural equation modeling were
used to examine a measurement model and a full latent variable model, respectively. A
covariance structure model, a full latent variable model, was formulated and consisted of the
measurement model and the structural model (Byrne, 2001). The measurement model
presented the links between latent variables and their observed measures; the structural model
presented the causal links between latent variables. One of the structural equation model
assumptions was that explanatory variables should be independent from each other (Byrne,
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2001). When these explanatory variables are highly correlated, multicollinearity exists. In
research aim 3, Pearson correlation analysis was used to examine the intercorrelations of
measurement indicators.

In the structural equation modeling, the length to time as an ACO

was treated as a ratio variable; the range of the length of time as an ACO was from 24 months
to 42 months.
Further, two major approaches were used to handle missing data in this study: recovery
of values and deletion from the list. When an ACO did not respond to the survey question
about the size range of the Medicare beneficiaries, the missing value was replaced with the
total number of Medicare beneficiaries from the ACO first-year performance dataset (if this
ACO was able to bed found in the performance dataset). Due to limitations in the 2013-2014
AHRF data, poverty and unemployment rates were accessed only through years 2013 and
2014, respectively. For 2014 and 2015 MSSP ACO cohort, the 2013 poverty rate was used to
instead of their current poverty rate. For 2015 MSSP ACO cohort, the 2014 unemployment
rate was used to instead of their current poverty rate. For research aim 3, the sample (n=343)
was large enough in the ACO year-one performance data, so any ACOs with missing values
(n=26) among the eight ACO aggregated indicators were excluded.

Confirmatory factor analysis (CFA) used to test a measurement model. Before
examining the full structural equation model, a measurement model should be tested by
confirmatory factor analysis. The analysis presents the relationship between the observed and
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the latent variables. The purpose of conducting the confirmatory factor analysis is to test the
hypothesized structure (Byrne, 2001). My study included the various observed variables
(indicators) as one latent variable: the actual ACO performance.

Figure 3 exhibits a generic measurement model of the actual ACO performance, which
is an endogenous latent variable. The actual ACO performance level was extracted from the
MSSP ACOs year-one performance results. ACO performance was represented by these eight
indicators: the satisfaction of patient/caregiver experience (AP1), the quality of care
coordination/patient safety (AP2), the potential beneficiaries coverage of preventive health
services (AP3), and the quality of care of the potential beneficiaries of these at-risk
populations—diabetes (AP4), hypertension (AP5), ischemic vascular disease (AP6), heart
failure (AP7), and coronary artery disease (AP8).
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Figure 3 The generic measurement model of the actual ACO performance: an endogenous
latent variable (eta_1).
Structural equation modeling (SEM) used to test full structural model. The SEM
with maximum likelihood estimation was used to examine the full structural model. One full
structural model for this study was created in this study, and its endogenous variable was
actual ACO performance. The exogenous variables were assessed through standardized
parameters, and the whole model was assessed through goodness-of-fit and the adjusted rsquared statistics. Figure 4 presents the covariance structure for the actual ACO model
performance. SEMs with maximum likelihood estimations were used to test how the actual
ACO performance was influenced by the contextual variables and ACO characteristic
variables, as well as how early an ACO model was adopted. In the SEM, the length to time as
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an ACO was treated as a ratio variable; the range of the length of time as an ACO was from
24 months to 42 months.

Figure 4 Predictors of the actual ACO performance: the generic full model.
Evaluation of goodness-of-fit of a model. In a SEM, researchers do not reject the null
hypothesis because, as Byrne (2001) indicated, “the postulated model holds in the
population” (p. 78). There are a variety of perspectives for evaluating the goodness-of-fit of a
model. Most goodness-of-fit statistics have either clear cutoff points or ranges to indicate
whether the model is a good-fit or poor-fit. Guidelines for acceptable fit include a nonsignificant Chi-square (X2), comparative fit index (CFI) greater than 0.90, root mean square
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error of approximate (RMSEA) less than 0.1 with a maximum upper bond of 90% of CI of
0.1, and standardized root mean square residual (SRMR) less than 0.10 (Weston, 2006). A
significant X2 indicated the model does not fit the sample data. A CFI value close to 0.95
indicated a good-fit model to the data. A RMSEA corrects for a model’s complexity. When
the RMSEA value is less than 0.05 or greater than 0.1, it indicates a good-fit or poor-fit for
the data, respectively. A SRMR summarizes how much difference exists between the
observed data and the model. Thus, a SRMR of 0.00 indicates perfect fit.
Also, a misfit in a CFA model can be identified via the residual value and modification
indices (MI) value. For example, a large MI value would indicate the presence of factor
cross-loadings (Byrne, 2001).
Sample Size Estimation
A-prior sample size calculation for multiple regression. In this study, the minimum
required sample size for a multiple regression was 112, which was calculated by a small
anticipated effect size (0.1), three predictors, the desired probability level at .05, and the
desired statistical power level at .08 (Soper, 2015).
A-prior sample size for SEM. The total parameters of a SEM model are used in
calculating a sufficient sample. Three types of parameters are: directional effects, variance,
and covariances (Weston, 2006). The directional effects include factor loadings and path
coefficients. The variance parameters include: indicator error (only include free parameters),
variance in the endogenous latent variables, and variance in the exogenous latent variables.
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The covariances parameter is a non-directional association between exogenous variables.
Kline (1998) suggested that one estimated parameter should have 10 to 20 participants. Based
on this guideline, in order to examine the model in Figure 4, this study should collect at least
a sample size of 430 participants from the MSSP ACO first-year performance dataset.
However, Weston (2006) pointed out that a minimum sample size of 200 is sufficient if the
research does not have any problems in the data.
Soper (2015) proposed another sample size calculation for SEM consisting of five
necessary parameters: anticipated effect size, desired statistical power level (1- beta), number
of latent variables, number of observed variables, and probability level (alpha). I assumed a
small effect size (0.1), and I set the alpha level at 0.05 and the beta level at 0.2 to minimize
the Type I and Type II errors. Based on Soper’s guideline (2015), I would have needed at
least 200 participants to test the models in Figure 4; I had 317 participants collected from the
MSSP ACO first-year performance dataset, so I could test the model in Figure 4.
Ethics Approval
Approval for the ACO survey and general approval to conduct the research was
obtained from the University of Central Florida’s Institutional Review Board (IRB) (SBE-1511613). The IRB approval letter is provided in Appendix B.
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CHAPTER FIVE RESULTS
Two major sources were applied to examine ACO formation, executives’ perceptions of
performance, and ACO first-year performance in this study. First, A survey of 2012, 2013,
2014, and 2015 MSSP ACO cohorts was conducted by this study. By the end of 2015, the
MSSP ACO first-year performance was collected for the 2012, 2013, and 2014 ACO cohorts.
The sample difference was in 2015 MSSP cohort involvement.
This chapter presents the results of my ACO survey and the ACO year-one
performance data. The findings of my ACO survey are reported in terms of a potential impact
of non-response bias, respondent characteristics, and two predictive models for the early
adoption of an ACO model and executives’ perceptions of overall organizational
effectiveness. The results of ACO year-one performance data are presented to illustrate model
building for actual ACO performance. The result of the measurement model is provided to
construct validation; this helps researchers build a covariance structure model for actual ACO
performance. Finally, the summary of findings is exhibited at the end of this chapter.
Comparability in Major Characteristics Between Respondents and Non-Respondents
After four months of survey distribution from October 2015 to February 2016, there
were 61 respondents (13.65% response rate). Of 61 respondents, only 48 and 41 sample sizes
were included in the binomial logistic regression and the multiple linear regression,
respectively. In order to understand the potential impact of non-response bias, Table 7
examines the baseline characteristics of ACOs’ differences between respondents and non68

respondents. The two groups were similar in the distribution of the year of ACO participation
and the average number of service areas. Non-respondent ACOs were in areas with slightly
higher poverty, unemployment rate, and market competition scores than respondent ACOs,
but no statistically significant differences were found. The respondents and non-respondents
did not significantly differ in the year of ACO participation, the average number of service
areas, poverty, unemployment rate, or market competition scores.
Table 7 Comparison of Baseline Characteristics of ACOs Between the Respondents
and Non-respondents Using Student-T test

Variable
Agreement with CMS
2012
2013
2014
2015
The Average Number
of Service Areas
(unit: state)
ACO Service Areas
Poverty rate
Unemployment rate
Market
Competition
Scores

Respondents
n=61
Mean/n
SD/%

Non-Respondents
n=386
Mean/n
SD/%

P-value

.292
18
9
19
15
1.36

29.5%
14.8%
31.1%
24.6%
.633

101
100
110
75
1.51

26.2%
25.9%
28.5%
19.4%
.970

.253

15.87
6.89
.0024

2.70
1.71
.0043

15.64
7.05
.0034

2.65
1.36
.0074

.540
.400
.333

Respondent Characteristics
Appendix D describes MSSP ACO characteristics from a survey conducted by this
research. According to the survey responses, 11.5% of MSSP ACOs participated in April 1,
2012, and 52.5% of MSSP ACOs were late adopters, whose contractual agreements with
CMS started in 2014 or 2015. Their average number of service areas was 1.36 states. Of the
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service areas, the poverty rate was 15.87, and the unemployment rate was 6.89%. The market
competition scores were .0024.

The survey showed that most ACOs were hospital-based

(59%), and 21.3% of ACOs had more than 20,000 Medicare beneficiaries. A majority of them
(82%) had implemented case management in their ACOs’ operation. Three-fourths of them
(75% of MSSP ACOs) spent less than one year seeking appropriate partners. The top three
facilitators influencing partners’ willingness to join an ACO were physician-led, shared
savings, and improvement of patient quality of care. On the other hand, inadequate capital for
information technology improvements was the biggest barrier inhibiting partners’ willingness
to join an ACO.
Appendix E shows the degree of information technology (sophistication of IT systems
in place) among MSSP ACOs in this survey. They usually collected financial performance
data (86.9%), population data (85.2%), and clinical outcome data (77.0%) for tracking and
analysis. More than half of MSSP ACOs claimed that more than 80% of their partners have
an electronic medical recorder (EMR) system. ACOs’ current information infrastructure’s
functionalities (65.27 vs. 52.50 points) and usage levels (65.19 vs. 49.49 points) were better
in the current year than they were in their initial adoption year. Also, the current integration
level of ACOs’ clinical and information systems were better in the current year than they
were in the initial adoption year (62.24 vs. 53.37 points).
Appendix F describes how ACO executives valued the ACO model and how they
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perceived organizational effectiveness in eight ACO quality domains. Of the MSSP ACOs,
the degree to which an ACO model was perceived by ACO executives to be consistent with
their existing values and past experiences was high (86.61 points). However, ACO executives
agreed that an ACO model was difficult to learn and operate (60.18 points). Among the eight
quality indicators of ACO organizational effectiveness, the heart failure quality with 72.15
points was more successful than the other seven quality indicators.
Comparison of the Early ACO and Late ACO Adopters
Table 8 describes the group comparisons of POET variables, Roger’s (1995) five care
characteristics, and the degree of information technology (sophistication of IT systems in
place). Early adopter ACOs in their service areas had significantly higher unemployment
rates (7.69% vs. 6.15%, p < .001) compared to late adopter ACOs. The major composition of
early ACOs was physician-led, in contrast to late adopter ACOs (76.2% vs. 40.7%, P = .014).
Currently, the early ACO adopters had a significantly higher degree of information
infrastructure in functionalities, usage levels, and integration levels compared to the late
adopters (71.73 points vs. 59.48 points, p = .019; 71.88 points vs. 59.46 points, p = .049;
72.95 points vs. 53.52 points, p= .015). However, Rogers’ five core characteristics of
diffusion of innovation and the degree of IT in the initial adoption year did not significantly
differ between early adopter ACOs and late adopter ACOs.
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Table 8 The Comparison of POET Variables, Rogers’ Five Core Characteristics and IT Degree
Between Early ACOs and Late Adopter ACOs (n=48)
Variables
Early ACOs
Late Adopter ACOs P-Value
(n=21)
(n=27)
Mean/n
SD/%
Mean/n
SD/%
ACO Service Areas
Unemployment

7.69

1.50

6.15

.92

<.001

Poverty

16.23

2.63

16.29

2.56

.935

Market Competition Scores

.0021

.0030

.0018

.0016

.744

12,882

6,808

11,712

7,136

.568

Total Number of Assigned Medicare
Beneficiaries

.014

Composition of ACO
Hospital-based

5

23.8%

16

59.3%

Physician-led

16

76.2%

11

40.7%

Overall

73.74

10.52

73.14

8.84

.819

Relative advantage

79.14

13.74

80.13

13.80

.785

Compatibility

88.21

7.48

85.16

9.17

.169

Complexity

61.28

16.28

59.25

12.67

.598

Trialability

70.77

23.48

67.74

23.48

.630

Observability

73.08

14.56

74.13

13.89

.782

The Degree of Information Collection

3.43

0.81

2.93

1.14

.094

The Degree of EMR

5.81

0.40

5.22

1.34

.059

ACO agreement start date

55.60

26.35

49.83

22.81

.392

Currently

71.73

20.97

59.48

16.66

.019

ACO agreement start date

55.43

26.37

44.23

21.47

.108

Currently

71.88

23.16

59.46

21.10

.049

ACO agreement start date

57.75

28.12

50.00

30.66

.383

Currently

72.95

26.62

53.52

26.81

.015

Executives valuing the ACO model (0 – 100
points)

Information Infrastructure’s Functionalities (0 –
100 points)

Information Infrastructure’s Usage Levels (0 –
100 points)

Integration Level of Your Clinical and
Information System (0 – 100 points)

Note:
Early ACOs: MSSP ACO’s agreement with CMS in 2012 or 2013
Late Adopter ACOs: MSSP ACO’s agreement with CMS after 2013
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Table 9 shows the predictors of the early adopter ACOs using multiple logistic
regression. Only five variables with statistical significance in Table 8 were included in the
final logistical regression model. When the predictors “unemployment”, “composition of
ACO”, “current information infrastructure’s functionalities”, “current information
infrastructure’s usage levels”, and “current integration level of clinical and information
system” were included in this model, the classification error rate declined, and the accuracy
rate increased from 56.3% to 83.3%.
More than one third (37.2%) of the variation in being early ACO adopters was
explained by the logistic model. There was a moderately strong relationship (Naqelkerke R
Square: 49.9%) between the predictors and the prediction. The probability of being an early
ACO adopter was higher in a physician-led organization than it was in a hospital-based
organization.

However, there was no statistically significant difference (OR=5.41, 95%

CI: .95 – 30.75). Current IT operation in functionalities, usage levels, and integration levels
did not affect early ACO adoption.

73

Table 9 Predictors of the Early Adoption of an ACO Model Using Multiple Logistic Regression
Analysis (N=48)
95% CI
Variable
B
S.E.
OR
Low
Upper
P-value
Constant
-8.26
2.51
.000
.001
Unemployment
.80
.35
2.23
1.13
4.39
.020
Composition of ACO
Hospital-based (Ref.)
Physician-led

1.69

.89

5.41

.95

30.75

.057

-.02

.062

.98

.87

1.11

.732

.02

.051

1.02

.92

1.13

.699

.03

.02

1.03

.99

1.07

.193

Current IT Degree (0100 points)
Information
Infrastructure’s
Functionalities
Information
Infrastructure’s
Usage Levels
Integration Level of
Clinical and
Information System

Cox & Snell R Square: 37.2%; Naqelkerke R Square: 49.9%

The Perceptions of Overall Organizational Effectiveness
Table 10 shows the POET variables and the degree of IT use associated with the
perceptions of organizational effectiveness. The correlation results showed that
unemployment rate (r = .438, p < .01) and early adopter ACOs (r = .579, P< .01) were
significantly positively associated with perceptions of organizational effectiveness. Table 11
describes the predictors of the perceptions of overall organizational effectiveness. Only two
significant factors in Table 10 were included in the multiple linear regression model. The
model’s adjusted R2 was 30.9%. The executives in the early adopter ACOs perceived their
organizations as more effective than did the late adopters, scoring 12.65 points higher in an
aggregate of eight ACO quality domains (p = .005).
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Table 10 Correlation of the POET Variables, the Degree of IT USE, and the Perceptions of Organizational Effectiveness Among the MSSP ACOs
Unemployment Poverty
Unemployment
Poverty
HHI
The Size of
Assigned
Medicare
Beneficiaries
Early Adopters
Hospital-based
Type of Information
Collection
EMR

1

The Number of
Assigned
Early
HHI
Medicare Adopters
Beneficiaries

.210
.021
1 -.425**
1

Type of
Hospital
Information
-Based
Collection

EMR

Current
IT1

Current
IT2

Current
IT3

Perceptions of
Performance

.126 -.003
-.368* .001
.213 .057

.382*
.157
-.030

.260
.194
-.017

.461**
.160
.090

.438**
.092
-.117

.183
-.245
.068

.641**
-.019
.075

.250
.154
-.229

1

.128

-.163

.324*

.121

.025

.106

.091

.026

1

.242
1

.261
-.303

.289
.179

.376*
.117

.321*
.1

.500**
.008

.579**
.267

1

.250

.176

.133

.320*

-.007

.134
.921**
1

*

.014
.293
.235
.117

1

Current IT1
Current IT2
Current IT3
Perceptions of
Performance

.105
1

.377
.641**
.570**
1

1

** P < .01; * P < .05
Refer to the following list for the definitions of abbreviations.
HHI: Herfindah-Hirschman index; EMR: electronic medical records; Current IT1: the degree of information infrastructure’s functionalities;
Current IT2: the degree of information infrastructure’s usage levels; Current IT3: the degree of integration level of clinical and information system.
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Table 11 Predictors of the Perceptions of Overall Organizational Effectiveness Using
Multiple Linear Regression Analysis (N=41)
Variable
Unstandardized
Standardized
t
P-value
Coefficients
Coefficients
B
S.E.
Beta
Constant
57.27
9.29
6.167
<.001
Unemployment
.980
1.486
.113
.660
.513
ACO Groups
Late Adopter ACOs
(Ref.)
Early ACOs
12.659
4.28
.507
2.959
.005
2
Adjusted R : 30.9%

The Measurement Model of Actual Performance
The detailed results for validating the initial measurement model of the actual ACO
performance are presented in Appendix G. The Chi-square test of absolute fit showed this
model was not a goodness-fit model because the P-value was less than 0.05 (X2:64.566;
degree of freedom (df): 20). In the other relative fit indices, only the RMSEA did not fit the
model very well. The Normal Fit Index (NFI) for the initial model was 0.927, below the
required 0.95. The CFI was 0.948, slightly below the required 0.95. The RMSEA indicated a
poor fit model because the RMSEA was 0.084, above the required 0.05.
Appendix H describes the standardized parameter and unstandardized factor loading in
the initial measurement model of actual performance. In order to improve the initial model,
only statistically significant indicators were retained.
in the revision to obtain a better-fitting model.

Modification indices were considered

However, all factor loadings in the initial

model showed statistically significant differences (p < 0.05), so none of them were removed
from the initial model.

Two pairs of residual covariances had large modification index

values (MI>= 10.00): e2 and e3; e5 and e8. Thus, in the revised model, the residuals of the
two pairs of error covariances were correlated to incorporate their shared variances.
Figure 5 shows the results of the revised measurement model with correlated errors of
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actual ACO performance. The Chi-square test of absolute fit was 24.783 with 18 degrees of
freedom. The other relative fit indices were much improved. The NFI for the revised model
was 0.972, above the required 0.95. The CFI was 0.992, above the required minimum of 0.95.
The RMSEA was 0.035, below the required 0.05. In conclusion, this model improvement was
19.89% [(64.566 – 27.783) / (20-18)]. Table 12 describes the standardized and
unstandardized factor loadings in the revised measurement model of actual performance.
All factor loadings (lambda values) are statistically significant. The strongest factor loadings
(> 0.8) of the revised model were quality domains in ischemic vascular disease (IVD) and
diabetes.

Figure 5 The Revised Measurement Model of The Actual ACO Performance: an Endogenous
latent variable (eta_3) (Standardized Estimates).
Note:
Sample size: 317, Chi-square = 24.783, Degrees of freedom = 18, Probability level = .131
CFI: 0.992; RMSEA: 0.035
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Table 12 The Revised Measurement Model of the Actual ACO Performance
Items
Description
Standardized
Unstandardized
S.E.
Factor loading
Factor loading
AP1

Patient/caregiver
.266
Experience
AP2
Care
.494
Coordination/
Patient Safety
AP3
Preventive
.612
Health
AP4
Diabetes
.808
AP5
Hypertension
.666
AP6
Ischemic
.858
Vascular
Disease
AP7
Heart Failure
.376
AP8
Coronary Artery
.763
Disease
Chi-Square: 24.783, DF: 18 ( P-value: .131)
* P-value < 0.05

Critical Value

.575

.127

4.518*

1.336

.157

8.492*

2.103

.198

10.646*

1.323
.683
1.090

.092
.068
.072

14.333*
10.095*
15.138*

.221
1.000

.034

6.418*

A Covariance Structure Model – Predictors of the Actual ACO Performance
The original covariance structure model (Figure 4 in Chapter 4) consisted of
institutional leadership model, timing of adoption of an ACO model, total number of assigned
Medicare beneficiaries, market competition scores, poverty, unemployment, and one
construct – the actual ACO performance. The actual ACO performance was an endogenous
measurement in this study.
Appendix I describes the results of initial covariance structure model for predictors of
actual ACO performance. The Chi-square test of absolute fit showed this initial model was a
poorly fitted model because its Chi-square was large (X2 =344.370; df = 82). Also, the other
relative fit indices were relatively low. The NFI for the initial model was 0.758, below the
required 0.95. The CFI was 0.801, below the required 0.95. The RMSEA was 0.101, above
the required 0.05.
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Statistically insignificant factors were excluded from the model in order to achieve a
better fit model. Appendix J presents the standardized and unstandardized parameter or factor
loadings for predictors of actual ACO performance in the initial covariance structure model.
Three factors, including market competition scores, the number of assigned Medicare
beneficiaries, and institutional leadership model, showed no statistically significant
relationship with the variable of the timing of adoption of an ACO model (P < .05). Six
pairs of residual covariance had large modification index values (MI>= 12): physician-led
and hospital-based ACO (1st pair); physician-led ACO and total number of assigned Medicare
beneficiaries in an ACO (2nd pair); hospital-based ACO and total number of assigned
Medicare beneficiaries in an ACO (3rd pair); market competition scores and poverty (4th pair),
poverty and unemployment (5th pair); hospital-based ACO and poverty (6th pair).

Thus, in

the revised covariance structure model, the residuals of these six pairs of residual covariance
were correlated to incorporate their shared variances for improving the goodness of fit.
Figure 6 shows a revised and nested covariance structure model for the predictors of
actual ACO performance. The Chi-square test of absolute fit had much improvement. Its Chisquares decreased to 156.745 (df = 81). The other relative fit indices were also improved, and
most of their results were close to the required values excluding NFI. The NFI for the revised
model was 0.890, below the required 0.95. The CFI was 0.945, slightly below the required
0.95. The RMSEA was .054, showing an excellent fit. In conclusion, this model improvement
was 177.626% [(334.371 – 156.745) / (82-81)] and statistically significant at the 0.05 level.
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Figure 6 Predictors of actual ACO performance: A revised covariance structure model
Sample size: 317, Chi-square = 156.745, Degrees of freedom = 81, Probability level = <.001
NFI 0.890; CFI: 0.943; RMSEA: 0.054
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Table 13 summaries the results of a revised covariance structure model for the
predictors of actual ACO performance. The variability in the actual ACO performance was
explained by the variables of the study with an R-square of 15%. The actual ACO
performance was significantly positively affected by the number of assigned Medicare
beneficiaries and hospital-based ACOs, and was significantly negatively affected by the
poverty rate, unemployment rate, and market competition scores. In other words, the actual
ACO performance was likely to be improved if ACOs had more Medicare assigned
beneficiaries or had hospital-based composition. On the other hand, if ACOs’ service areas
were located in areas of high poverty, a high unemployment rate, or a lower competitive
index, their ACO performance was relatively lower than their counterparts. In addition,
according to standardized regression coefficients, the total number of assigned Medicare
beneficiaries in an ACO and hospital-based composition exhibited as having the strongest
(.218) and the weakest direct effects (.123) on the actual ACO performance, respectively.
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Table 13 Predictors of the Actual ACO Performance: a Revised Covariance Structure Model
Predictor Variable

Dependent Variable

Standardized
Parameter or factor
loading

Unstandardized
Parameter or
Factor loading

S.E.

Critical
Value

ACO Service Areas
Unemployment

Timing of Adoption of
an ACO Model

.675

118.912

7.705

15.433*

Poverty

Timing of Adoption of
an ACO Model
Actual Performance
Actual Performance
Actual Performance
Actual Performance

-.184

-17.043

4.047

-4.211*

-.156
-.180
-.148
.218

-.060
-.036
-12.791
.000

.029
.012
4.988
.000

-2.054*
-2.962*
-2.564*
3.730*

Actual Performance

.123

.136

.064

2.120*

Actual Performance

.121

.000

.000

1.655

Actual Performance AP1 (Patient/Caregiver
Experience)

.268

.589

.130

4.546*

Actual Performance AP2 (Preventive
Health)

.495

1.361

.161

8.467*

Actual Performance AP3 (Preventive
Health)

.608

2.122

.202

10.480*

Actual Performance AP4 (Diabetes)

.814

1.354

.095

14.229*

Actual Performance AP5 (Hypertension)

.668

.696

.069

10.069*

Actual Performance AP6 (Ischemic Vascular
Disease)

.859

1.108

.074

14.926*

Actual Performance AP7 (Heart Failure)

.373

.223

.035

6.349*

Actual Performance AP8 (Coronary Artery
Disease)

.751

1.000

Unemployment
Poverty
HHI
The Number of
Assigned
Beneficiaries
Hospital-based
Timing of Adoption
of an ACO model

Chi-squares: 156.745, DF: 81

(P-value < .001)

* P-value < 0.05
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Summary of Findings
The major results of MSSP ACO characteristics from survey responses, multivariate
logistic analysis, multivariate linear analysis, and covariance structure model are summarized
in this section.
MSSP ACO characteristics from the survey. Of the 447 MSSP ACOs on the mailing
list, the response rate was 13.65 % (n=61). In other words, sixty-one MSSP ACOs
participated in the survey. There was a minimal potential impact of non-response bias in the
study. Of the 61 MSSP ACOs, 42 (52.5%) were late adopters whose contractual agreement
with CMS started in 2014 or 2015, and 36 (59.0%) had hospital-based composition. ACOs’
current degree of IT adoption in functionalities (62.27 vs. 52.50 points), usage levels (65.19
vs. 49.49 points), and integration levels (62.24 vs. 53.37 points) were better in the current
year than they were in the initial adoption year. The degree to which an ACO model was
perceived by ACO executives as being consistent with their existing values and past
experiences was high (86.61 points). However, ACO executives agreed that an ACO model
was difficult to learn and operate (60.18 points). In eight ACO quality domains, respondents
perceived the heart failure quality as more salient than the other seven quality indicators.
Multivariate logistic analysis and multivariate linear analysis. The multiple logistic
regression showed that MSSP ACOs were more likely to be early ACO adopters if their
service areas had high unemployment rates (OR=2.23; 95% CI: 1.13 - 4.39). Although
physician-led ACOs could likely be early adopter ACOs, there were no statistically
significant differences (OR, 1.69; 95 CI: .95-30.37). In the multiple linear regression analysis,
the executives in the early ACOs perceived their organizations as more effective than the late
adopters, scoring 12.65 points higher in an aggregate of eight ACO quality domains (p
= .005).
Covariance structure model. Three hundred and seventeen MSSP ACOs, with
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contractual agreements with CMS before 2015, had kept their year-one performance records
(the actual ACO performance with eight quality domains). The variability in actual ACO
performance was explained by the predictor variables of the study with an R-square of 15%.
The quality domains in ischemic vascular disease and diabetes were the strongest factor
loadings in the measurement of actual ACO performance. Actual ACO performance was
statistically significantly and positively affected by the number of assigned Medicare
beneficiaries and the hospital-based ACO, and was significantly negatively affected by the
poverty rate, unemployment rate, and market competition scores. In other words, the actual
ACO performance was likely to be improved if ACOs had more Medicare assigned
beneficiaries or had hospital-based composition. On the other hand, if ACOs’ service areas
were located in areas of high poverty or high unemployment, or showed a lower competitive
index, their ACO performance was relatively lower than their counterparts.
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CHAPTER SIX DISCUSSION
This chapter presents the results of individual hypothesis testing and interpretation by
research aims. The discussion about determinants of being early adopters includes three
hypotheses from the first research aim. The discussion about determinants of ACO Model’s
performance contains three hypotheses regarding subjective performance (executives’
expectations of performance) and two hypotheses regarding objective performance (actual
performance). At the end of this chapter, limitations of the study are presented.
Hypothesis Testing and Interpretation
Determinants of being early adopters of ACO.
H1a: The hospital-based network affiliated organizations adopts an ACO model earlier
than the physician-led organizations.
H1b: Organizations with a higher degree of information technology are more likely to
be identified as an early adopter of the innovation related to ACO.
H1c: Executives valuing the ACO model are more likely to adopt an ACO earlier.

All three hypotheses were not supported by the survey data. The results indicated that
contextual variables, such as unemployment rates in ACO service areas, relatively influenced
how early an ACO model was adopted. Although Hikmet et al. (2008) found that
organizational characteristics can explain a high adoption variance of 37.4%, Hikmet et al.
did not include how other factors might influence IT adoption, such as contextual
(environmental) variables. My study findings might imply that some contextual variables
(such as unemployment rate) are important to an ACO model adoption. In addition,
organization locations with a low poverty rate, a low unemployment rate, or a high income
level increased the likelihood of adopting an innovation in healthcare (Menachemi et
al.,2012; Castle, 2001); the three related indicators (poverty rate, unemployment rate, and
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income level) might have shared a theoretical or latent construct, such as socioeconomic
status (SES) at the county level (Matthews & Gallo, 2011; Ramirez-Valles, Zimmerman, &
Newcomb, 1998). The service areas of early ACO established by August 2012 had higher
SES, as compared with areas without ACO (Lewis et al., 2013). As compared to the early
adopters, my study showed the service areas of late adopter ACOs had lower unemployment
rates. This might imply later ACOs would be more likely to form in the area with higher SES.
The sample selection and the type of ACO design for Medicare might be another possible
reasons to explain why early ACO adopters formed in areas with higher unemployment rates.
Institutional leadership models. Of 61 MSSP ACOs, the hospital-based network
affiliation model was the major composition of ACOs (59%). However, the composition of
ACO category showed a big difference between early adopter ACOs and late adopters; only
23.8 percent of the early adopter ACOs were hospital-based models. This finding is
inconsistent with the H1a hypothesis, which might be because of differing interpretations of
ACO integration among physician-led ACOs and hospital-based ACOs. Independent
practices and medical groups kept their operations as usual in the ACO integration. In
contrast to a hospital and an integrated delivery system, executives in a hospital or an
integrated delivery system perceive ACO integration as an equal partnership and a cultural
change, so integration within an ACO became a long journey (Kreindler et al., 2012). Also, in
acute care hospitals, the leadership support or commitment can influence managers’
willingness to participate in ACOs (Wan, Masri, Ortiz, & Lin, 2014). Whether to form an
ACO is a complex and time-consuming decision for hospital-based organizations.
On the other hand, Shortell, et al. (2014) noted that larger physician practices are more
likely to become an ACO than are other forms of health care organizations. Generally, it is
easier to meet a minimum standard of Medicare beneficiary size if physician practices
become prevalent in the MSSP ACOs. Physicians in ACO practices receive higher
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compensation for quality, compared with those in non-ACO practices (Ryan, Shortell,
Ramsay, & Casalino, 2015). This might encourage physicians, who have strong beliefs in
pay-for-quality, to adopt an ACO model earlier. This information might also explain why
most of the early adopter ACOs group is dominated by the physician-led model.
Degree of IT(sophistication of IT systems in place). In my study, the degree of
information technology (sophistication of IT systems in place) upon initial ACO adoption
was similar, regardless of whether they were early or late adopters; further, their information
infrastructure’s functionalities, usage levels, and integration levels were at the stage of
planning to be implemented. Not surprisingly, Greenhalgh, et al., (2008) showed that
innovation adoption was easier for and more widely chosen by organizations that already had
key IT functionalities. Currently, early adopter ACOs’ information infrastructures are
partially implemented, but the late adopters are still at the stage of planning to implement.
This information might imply that some early adopter ACO executives shares similar visions
in terms of developing their information technology infrastructure in their initial adoption
periods. Also, my research showed that ACOs with longer histories of operation had higher
implementation levels. However, Sheikh, Patel, Manning, & Sacks (2011) argued that a
complex innovation might delay or slow down the implementation phase, making it proceed
much more slowly.
Executives valuing the ACO model. How early an ACO model was adopted is not
influenced by executives’ attitudes and beliefs regarding the ACO adoption. The early
adopters have a slightly higher score in the compatibility attribute, compared with the late
adopters, but there is no difference among the other four ACO attributes between early and
late adopters. However, among the five ACO attributes, the score of a compatibility attribute
is the highest, regardless of ACO status as early or late adopter. This result is consistent with
previous findings that a higher compatibility increases the likelihood of adopting an
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innovation (Alkraiji et al., 2013; Sams et al., 2013; Peeters et al., 2012; Hsu et al., 2013;
Morton & Wiedenbeck, 2009; Spaulding et al., 2005; Chew et al., 2004; Pronk et al.,2002).
Determinants of ACO model’s performance.
H2a: Among those adopting the hospital-based network affiliation model, their
executives’ perceptions of performance are higher than the physician-led model.
H3a: Among those adopting the hospital-based network affiliation model, their actual
performances are higher than the physician-led ACO model.

Institutional leadership models. H2a was not supported, but H3a was supported. The
results indicate that the hospital-based network affiliation model has better actual ACO yearone performance than the physician-led ACO model, but executives’ perceptions of
performance are no different between the two models. The advantages of specific ACO
models were explored by previous ACO studies, but no clear evidence has been shown to
indicate any competitive advantage of one over another (Fisher et al., 2007; Crosson, 2009;
Colla et al., 2014; McWilliams et al., 2016; Mostashari et al., 2014; McWilliams et al., 2015;
Wexler et al., 2014; Phillips et al., 2011). ACOs’ ability to manage hospital-related aspects of
patient care was similar between ACOs involving hospitals and those without hospitals
(Colla, Lewis, Tierney, & Muhlestein, 2016).
Overall, my study has shown that Medicare beneficiaries’ number and status as
hospital-based ACO are important in predicting actual ACO performance. This result is
consistent with Crosson’s (2009) comments about economies of scale and Cigna
Corporation’s successful ACO experiences regarding hospitals and doctors (Herman, 2015).
In an early performance analysis for 2012 and 2013 MSSP ACO cohorts, independent
primary care groups had a better ACO performance in total adjusted annual Medicare
spending than hospital-integrated groups (McWilliams et al., 2016). There are two possible
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explanations why my study finding is inconsistent with McWilliams’ (2016) research: the
differences in sample size and measurement of performance. An additional 2014 ACO cohort
included in my study might represent real performance differences. Although a positive
correlation might appear between ACO quality and annual Medicare spending savings, the
strength of association is unknown. In other words, if the association between ACO quality
and Medicare spending savings is not strong, improved ACO quality might not necessarily
lead to better savings, especially for first-year or early performance.
H2b: Among those organizations with a higher degree of information technology,
their executives have higher perceived performance of ACOs.

The degree of IT (sophistication of IT systems in place). H2b was not supported. My
results indicate that executives’ perceptions of performance are not directly influenced by a
degree of information technology in functionalities, usage levels, and integration levels.
However, early adopter ACOs are the strongest factor in the perception of performance
model; there is a positive association between the early adopters and the degree of
information technology (Its Pearson r rang is from 0.376 to 0.50). This may imply that the
degree of information technology could have an indirect influence on executives’ perceptions
of performance through the early adopter ACO variable. In other words, a higher degree of IT
could still produce a desired effect on ACO performance (Vedel et al., 2013; Barnes et al.,
2014; Perez, 2014; Parker & Aronoff, 2015; Batson & Batson, 2015; Hagland, 2014). The
indirect effects of IT degree could be examined in future studies.
The other possible reason might be that it is not easy to notice a short-term impact of
IT for organizations because of high initial outlays and operating costs of IT adoption
(Edwardson, Kash, & Janakiraman, 2016). Also, a 9-year study showed that a positive
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financial impact of electronic health record (EHR) on health care providers was still small
after a 4-year time period post-EHR implementation (Lim et al., 2015).
H2c: Late adopters have higher perceptions of performance than early adopters.
H3b: Late adopters have higher actual ACO performances than early adopters.

Timing of the adoption of an ACO model. H2c and H3b were not supported by the
data. The executives in the early adopter ACOs perceived their organizations to be more
effective than did the executives of the late adopters. However, the actual ACO model’s yearone performance was not strongly influenced by the timing of adoption of an ACO model.
The actual ACO performance was significantly negatively affected by the poverty rate and
unemployment rate, and was significantly positively affected by the number of assigned
Medicare beneficiaries, the hospital-based ACO, and the score of competitive index. This
result indicates that determinants of subjective organizational performance were not
consistent with the objective performance.
For the ACO model’s year-one performance, by the end of 2015, my study was able to
include three ACO cohorts (2012, 2013, and 2014), and their year-one performance was used
as a basis for comparison. In contrast to subjective assessment of performance (executives’
perceptions of performance), executives rated their current overall organizational
effectiveness in eight ACO quality domains between October 2015 to February 2016; as such,
executives in the 2013 ACO cohort rated their third year performance, and those in the 2015
ACO cohort rated their first year performance. This may explain why the timing of adoption
of an ACO model did not have an impact on the actual ACO model’s year-one performance
but did impact the executives’ perceptions of performance.
My study results also indicated that the early ACO adopters have higher perceptions of
performance than the late adopters, but it was not consistent with the organizational learning
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perspective (Huber, 1991). This may imply that the late adopters could benefit from
knowledge acquisition, information distribution, information interpretation, and
organizational memory, but an ACO model’s performance might be strongly moderated by
environmental and organizational structure factors (Jacobs et al., 2015). This explanation is
possible because organizational and environmental factors, such as total number of assigned
Medicare beneficiaries, hospital-based ACO, and poverty rate at the state level, showed a
greater effect on the actual ACO performance in my study.
Limitations of the Study
Overall, this study offers exciting new knowledge about organizational performance
among ACO adopters in recent years. However, there are three major research limitations in
this study: 1) I had to use a variety of sample sizes that were based on different data sources
and research aims; 2) the results might have been impacted by a relatively low survey
response rate; and 3) the study time frame and duration of observation were limited. Even
though these limitations exist, the study results reveal significant findings that may assist in
the future modeling of ACOs, such as the core principles of the best ACO model.
In the first and second research aims, the maximum size of 432 MSSP ACOs should be
included in the analytical stage if a 100% response rate has been achieved, and no ACO
leaves the Medicare share savings program. As of October 2015, only 405 ACOs can be
found in the searchable list of Medicare Shared Savings Program ACOs. Sixty-one
executives among these 405 ACOs participated in my email survey, so the response rate was
15.06%. In order to include ACOs with comprehensive data at the analytical stage, only 41
ACOs are included in a predictive model for the perceptions of overall organizational
effectiveness; this sample size does not meet the minimum required for a prior sample size (n
= 112), which has an 80% or higher power (1-β) to observe a small estimated treatment effect
size (0.01). Even if the estimated treatment effect size in my study would have been a true
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effect size, or, if the true treatment effect size had been even smaller, it would still have been
necessary to collect a larger sample size to increase the power of a hypothesis test. Otherwise,
the conclusion of research aim 2 (executives’ perceptions of performance would not be
influenced by the type of institutional leadership model and the degree of information
technology) would fall into a Type II error.
In contrast to the first and second research aims, the 2015 ACO cohort is not included
in the third research aim because of limited data availability. By the end of 2015, only 2012,
2013, and 2014 ACO cohorts’ year-one performance was accessible. A total of 317 ACOs
with comprehensive year-one performance records was used to examine the determinants of
actual ACO performance (excluding 26 ACOs); 317 was a sufficient sample size to justify
using a structural equation model in my study, according to Soper’s (2015) guideline of apriori sample size calculator for structural equation models. Because of the various samples
sizes in subjective and objective ACO performance, I needed to carefully explain my study
findings and avoid misleading conclusions.
Medicare shared savings program (MSSP) ACO performance results are released
annually in October. Because of the study time frame limitation, this study examined only the
first-year MSSP ACO performance from the 2012, 2013, and 2014 ACO cohorts. In order to
observe the actual impact of ACO adoption, it is imperative to observe both short-term and
long-term effects in future research.
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CHPATER SEVEN IMPLICATIONS AND CONCLUSIONS

This chapter presents some imperative implications indicated by my research findings,
which are aimed at researchers in the evaluation of national demonstration programs,
healthcare executives/managers, and policy makers. Also, several ideas for future research
and the significance of my conclusions are listed at the end of this chapter.
Implications of the Study
Theoretical implications. In the health care reform era, the use of an integrative
framework becomes an empirical study of understanding the ACO adoption and
implementation. Not only might ACO executives’ attitudes toward innovation directly
influence an ACO adoption, the social system (Duncan’s (1959) ecological complex model)
also affects adoption. Therefore, this study proposed a theoretical integrative framework
using Rogers’ (1995) diffusion of innovation theory and Duncan’s (1959) POET model to
examine ACO formation and ACO performance. My theoretical approach was different from
Shortell’s (2016) framework for ACO innovations, which used four perspectives from
organization theory: institutional theory, transaction cost economic theory, high-reliability
organization theory, and organizational learning theory. However, the former and the latter
frameworks are similar in considering the effects of environmental/contextual and
organizational variables. For example, this study indicated that contextual variables, such as
unemployment rates in ACO service areas relatively influenced how early an ACO model
was adopted. The ACO first-year performance was positively affected by organizational
variables (e. g. the number of assigned Medicare beneficiaries and the hospital-based ACO)
and is negatively affected by contextual variables (e. g. the poverty rate, unemployment rate,
and market competition scores).
Methodological implications. The outcome variables from previous ACO related
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studies were a single indictor, such as cost savings or patients’ experience (McWilliams et al.,
2015; McWilliams et al., 2014; Colla et al., 2016; McWilliams et al., 2016). This study is the
first research to apply a measurement model that included eight observed variables
(indicators) to reflect the concept of ACO performance. In addition, the result of the ACO
measurement model is provided to construct validation; this helps researchers to build a
covariance structure model for the ACO first-year performance.
Managerial implications. The CMS, a public ACO, reported (2015) that ACOs with
experience in coordinating care for patients across care settings are likely to have better
performance in their first year (Evans, 2015). Cigna Corporation, a private-payer ACO,
reported in 2015 that only 58% of large-group ACOs achieved the goal of lower costs and
better quality; therefore, managers still would like to know more about ACO performance
among different ACO affiliations (Herman, 2015). My research studied this type of
performance at the organizational level, and it focused on ACO performance instead of
examining the effects of an ACO model intervention. The findings indicate that the MSSP
ACO first-year performance is relatively better if ACOs had more Medicare assigned
beneficiaries or had hospital-based composition. If ACOs’ service areas were located in a
high poverty area or the area had a high unemployment rate or a lower competitive index, the
ACO performance would be relatively lower than their counterparts. For managers, the total
Medicare size and the hospital-based composition are relatively controllable factors. This
study would suggest that managers consider strategies for increasing economies of scale in
size and securing hospital involvement in their ACOs for more effective management.
Health policy implications. By the end of 2018, the U.S. Department of Health and
Human Services expects 50% of Medicare payments will be made on the basis of the quality
of care; adoption of more ACOs is one of methods available to reach this goal (Radnofsky &
Beck, 2015). In my survey findings, inadequate capital for information technology
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improvements was the biggest barrier inhibiting healthcare providers’ willingness to join an
ACO. For non-ACO healthcare providers, the inadequate capital issue might be able to be
addressed through an ACO investment model that provides pre-paid savings, especially for
rural and underserved areas (CMS, 2015a). Financial support is a key element for rural or
urban areas; however, financial support is still important for those potential ACO participants
who are planning to invest in necessary infrastructure.
My survey results showed that shared savings were an important facilitator influencing
partners’ willingness to join an MSSP ACO. In the Next Generational ACO Model (NGACO
Model), ACOs take higher levels of financial risk and reward than current ACO models
(CMS, 2015a). Organizations considering the NGACO model need to maintain at least
10,000 Medicare beneficiaries, which is double the size required by the MSSP ACO
(Champagne, Gusland, & Mills, 2016). According to the findings from the MSSP ACO firstyear performance, there is a positive association between the total Medicare beneficiary size
and ACO performance. This evidence might support CMS’s hypothesis about the new
NGACO model, which proposes that strong financial incentives for ACOs will yield better
performance in patient outcomes and costs. On the other hand, hospitals-involved ACOs also
showed better performance than those ACOs without hospital involvement. This information
might help health policy makers define the core principles of the best ACO model of the
future.
Suggestions for Future Research
Medicare shared savings program (MSSP) ACOs performance results are released
annually in October. By the end of 2015, I was able to study only the first-year MSSP ACOs’
performance from the 2012, 2013, and 2014 ACO cohorts. Further researchers not only might
include the subsequent MSSP ACO cohorts to monitor their first-year performance, and to
examine the stability of MSSP ACO performance during the first and second year, utilizing a
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panel regression model of a factorial structure. The hypothesized panel model of factorial
structure for the MSSP ACO performance at the first and second year would include eight
indicators: satisfaction of patient/caregiver experience, the quality of care
coordination/patient safety, the potential beneficiaries coverage of preventive health services,
and the quality of care of the potential beneficiaries of these at-risk populations: diabetes,
hypertension, ischemic vascular disease, heart failure, and coronary artery disease.
This study also revealed that the economic scale in size and hospital involvement
positively influenced first-year ACO performance. Burns and Pauly (2012) emphasized that
better coordination of care would improve quality at any given cost. Two major
measurements should be considered for future research: 1) the detail of a hospital’s
involvement in an ACO, and 2) core elements of successful coordination of care within an
ACO. The predictors in the executives’ perceptions ACO performance and the actual yearone ACO performance were inconsistent in this study. Examining the association between the
perceptions and actual performances might be an important topic for further exploration to
determine their causal relationship.
Conclusions
This study makes a unique contribution using a theoretically integrated framework with
Rogers’ (1995) diffusion of innovation theory and Duncan’s POET model (1959) to examine
ACO formation and ACO performance. In summary, among the early ACO adopters, threefifths of all ACOs had hospital involvement; their current IT degree in functionalities, usage
levels, and integration levels were higher than the same indicators were in the late ACO
adopters. This study demonstrates that contextual variables, such as unemployment rates
within ACO service areas, relatively influenced how early an ACO model was adopted.
Executives in the early adopter ACOs had higher perceptions of overall organizational
effectiveness, as compared with the late adopters. The first-year performance of 2012, 2013,
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and 2014 ACO cohorts was positively influenced by the number of assigned Medicare
beneficiaries and hospital-based ACO, and it was negatively influenced by the poverty rate,
unemployment rate, and market competition scores (Herfindah-Hirschman Index).
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APPENDIX A: THE SURVEY OF THE DIFFUSION AND PERFORMANCE
OF THE ACCOUNTABLE CARE ORGANIZATION MODEL
Dear Sir/ Madam:
This study is being conducted by the College of Health and Public Affairs at the University of
Central Florida. The purpose of the study is to identify CEOs’ perceptions of factors influencing
the organizational formation and transformation to ACOs and their ACOs’ performances.
The research team would greatly appreciate your completing this online survey processed via
the Qualtrics.Com. The survey will take less than 15 minutes to complete. All your responses
will be kept confidential. Only people directly involved with this project will have access to the
survey. The results of this study will help us understand the changing delivery system in the U.S.
No organizational or personal identifiable information will be revealed in any written reports or
articles.

If you have any questions, concerns, or complaints about this survey, you can contact the
person(s) below:
Yi-Ling Lin, M. S.
Ph.D Candidate, Hlth Svcs Mgt & Resrch Trk

Thomas T.H. Wan, Ph.D.
Professor and Associate Dean

College of Health and Public Affairs, HPA1

College of Health and Public Affairs, HPA1

University of Central Florida,
Orlando, FL 32816

University of Central Florida,
Orlando, FL 32816

Email: yllin@knights.ucf.edu

Email: Thomas.Wan@ucf.edu

This study has been reviewed and approved by The University of Central Florida
Institutional Review Board (IRB). It is your rights to report any complaint to IRB.
Research at the University of Central Florida involving human participants is carried out
under the oversight of the UCF IRB.
Institutional Review Board,
University of Central Florida,
Office of Research & Commercialization,
12201 Research Parkway, Suite 501, Orlando,
FL 32826-3246
Tel: 407-823-2901
I hope that you will be able to participate and help us in this study.
Sincerely,
Yi-Ling Lin, M. S.
Ph.D Candidate, Hlth Svcs Mgt & Resrch Trk
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Q1: When did your ACO start to participate in the CMS Medicare Shared Savings Program?
____ April 1, 2012
____ July 1, 2012
____ January 1, 2013
____ January 1, 2014
____ January 1, 2015
Q2: Before applying to the CMS Medicare Shared Savings Program, how much time did your
team spend seeking appropriate doctors, hospitals, and healthcare providers to develop an
ACO?
____ Less than 6 months
____ 6 –12 months
____ 1 – 1.5 years
____ 1.5 –2 years
____ 2.5 – 3 years
____ More than 3 years
Q3: From the management perspective, what are the facilitators influencing your partners’
willingness to join your ACO:
Strongly
Disagree
Q3.1: Improvement of population health
Q3.2:Improvement of patient quality of care
Q3.3:A focus on the patient
Q3.4: Physician-led
Q3.5: Lower costs
Q3.6: Shared savings
Q3.7: Increased provider market niche/power
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Disagree

Agree Strongly
Agree

Q4: What are the barriers inhibiting your partners’ willingness to join your ACO:
Strongly
Disagree

Disagree

Agree Strongly
Agree

Disagree

Agree Strongly
Agree

Q4.1: Legal and regulatory barriers
Q4.2: The mission of their own organizations
Q4.3: Anticipation of losing autonomy
Q4.4: Population base is not large enough
Q4.5: Inadequate capital for information
technology improvements
Q4.6: Payment structure/financing
Q4.7: No ACOs in their areas to their
knowledge
Q4.8: No ACOs in their area wish to partner
with them at that time to their
knowledge
Q5: Please describe how you perceived the ACOs’ advantages:
Strongly
Disagree
Q5.1: ACOs increase provider market
niche/power.
Q5.2: ACOs create a good incentive to lower
patients’ health care cost.
Q5.3: ACOs are able to have health care
providers work together to treat an individual
patient across care settings. Therefore, the
patient and providers can be true partners in
care decisions.
Q5.4: Through the ACO, health care providers
have information about all other services
provided to the beneficiary. Therefore, patients
can receive the effective seamless care.
Q5.5: Overall, the effort of ACO is worthy of
the financial and technical investments.
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Q6: Please describe how you perceived the ACOs’ compatibility with your value:
Strongly
Disagree

Disagree

Agree Strongly
Agree

Disagree

Agree Strongly
Agree

Q6-1: I have a strong belief that the best care is the
patient-oriented or patient-centered care.
Q6-2: I have a strong belief that pay-forperformance method is a major initiative in
changing Medicare payments.
Q6-3: I am experienced in finding proper partners
to work together in the healthcare field.
Q6-4: I am experienced in building a team-based
care.

Q7: Please describe how you perceived the ACOs’ complexity:
Strongly
Disagree
Q7-1: In my ACO, it is easy to find proper partners
to meet the amount of Medicare Fee-for-Service
patients, at least 5,000.
Q7-2: In my ACO, organizational culture
differences among partners do not influence me to
build a team-based care.
Q7-3: In my ACO, the information infrastructure
differences among partners do not influence my
operation.
Q7-4: In my ACO, partners totally understand how
the federal government pays for the care and how
our medical decisions should be changed.
Q7-5: In my ACO, partners are able to follow the
new patient referral system.
Q7-6: In my ACO, It is not a challenge to collect
33 ACO indicators from partners and to submit
quality measures to CMS on time.
Q7-7: ACO must sign an agreement with CMS to
participate in the Shared Savings Program for a
period of at least 3 years. This agreement makes
me think that this time period is proper for an ACO
trial.
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Q8: Please describe how you perceived the Observability of ACOs’ results:
Strongly
Disagree Agree Strongly
Disagree
Agree
Q8-1: CMS factsheet about ACOs help me to
know the status of the participating ACOs.
Q8-2: CMS factsheet about ACOs help me to
see the performance of ACOs.
Q8-3: Other health care systems’ experiences
about ACOs help me to evaluate whether ACO
is worthy of the administrative change and
technical investments.
Q8-4: Through ACOs, I expect that doctors
within my partnership network can improve
care coordination.
Q8-5: Through ACOs, I expect that my
partners can reduce wasteful health care
spending for obtaining shared savings.
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Q9: Please select the best identifier that describes your type of organization (Check only one)
_____ Medical group practice
_____ Network of individual practices (e.g., IPA)
_____ Physician network
_____ Hospital system(s)
_____ Integrated delivery system
_____ Partnership of hospital system(s) and medical practices
_____ Other, please describe__________________________
Q10: How many beneficiaries does your ACO serve?
____ 5,001 -7,500 beneficiaries
____ 7,501 - 10,000 beneficiaries
____ 10,001 - 12,500 beneficiaries
____ 12,501 - 15,000 beneficiaries
____ 15,001 - 17,500 beneficiaries
____ 17,501 - 20,000 beneficiaries
____ More than 20,000 beneficiaries
Q11: Has your ACO used “case management” or “care coordinator” in its operation?
____Yes
____ No
Q12: What type of information does your ACO collect for tracking and analysis? (Please
check all that apply.)
____ Population data (i.e. Demographic data)
____ Clinical outcome data
____ Financial performance data
____ Productivity data
____ Our ACO does not collect information for tracking and analysis
____ Other data (Please Specify.)__________________________
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Q13: Which of the following best describes your partners’ information infrastructure under
your ACO?
____ No partners have an electronic medical records (EMR) system (Go to Question
17)
____ Less than 20% of partners have an electronic medical record (EMR) system
____ Between 21% - 40% of partners have an electronic medical record (EMR) system
____ Between 41% - 60% of partners have an electronic medical record (EMR) system
____ Between 61% - 80% of partners have an electronic medical record (EMR) system
____ More than 80% of partners have an electronic medical record (EMR) system
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Q14: Please identify your information infrastructure’s Functionalities at the two different periods.
Period
Q14.1: The system supports the
continuity of care
document as the
harmonized format for the
exchange of clinical
information including
patient demographics,
medications and allergies.

ACO
agreement
start date

Q14.2: The system identifies and
maintains a single patient
record for each patient.

ACO
agreement
start date
Currently

Q14.3: The system captures and
maintains demographic
information. Where
appropriate, the data
should be clinically
relevant, reportable, and
traceable over time.

ACO
agreement
start date

Q14.4: The system includes
extensive error checking
of all user input data,
including, but not limited
to: Check ICD9 or 10
diagnoses against gender,
age, other as necessary
and proper diagnosis.

ACO
agreement
start date

Q14.5: The system is capable of
generating lists of patients
with specific conditions to
use for quality
improvement, reduction of
disparities, research or
outreach.

ACO
agreement
start date

Not
Planning to be
implemented implemented

Currently

Currently

Currently

Currently

106

Partially
Fully
implemented implemented

Q15: Please identify your information infrastructure’s Usage Levels at the two different periods.
Periods
Q15.1: The system supports the
continuity of care
document as the
harmonized format for the
exchange of clinical
information including
patient demographics,
medications and allergies.

ACO
agreement
start date

Q15.2: The system identifies and
maintains a single patient
record for each patient.

ACO
agreement
start date
Currently

Q15.3: The system captures and
maintains demographic
information. Where
appropriate, the data
should be clinically
relevant, reportable, and
traceable over time.

ACO
agreement
start date

Q15.4: The system includes
extensive error checking
of all user input data,
including, but not limited
to: Check ICD9 or 10
diagnoses against gender,
age, other as necessary
and proper diagnosis.

ACO
agreement
start date

Q15.5: The system is capable of
generating lists of patients
with specific conditions to
use for quality
improvement, reduction of
disparities, research or
outreach.

ACO
agreement
start date

Not
Planning to be
implemented implemented

Currently

Currently

Currently

Currently
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Partially
Fully
implemented implemented

Q16: Please describe the Integration Level of your clinical and information system at the
two different periods.
Periods
Q16.1: The system has the
capability to submit
diagnostic test orders
based on input from
different care providers.

ACO
agreement
start date

Q16.2: The system has the
capability to print orders
for manual transmission.

ACO
agreement
start date
Currently

Q16.3: The system has the
capability to fax orders.

ACO
agreement
start date
Currently
ACO
agreement
start date
Currently

Q16.4: The system accepts orders
from multiple locations.

Q16.5: The system has the
capabilities to share results
with different healthcare
providers.

Not
Planning to be
implemented implemented

Currently

ACO
agreement
start date
Currently
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Partially
Fully
implemented implemented

Q17: On a scale of 1 to 100 (from low to high), please rate your perceived performance at
eight domains
Q17.1 _____ Patient/Caregiver experience
Q17.2 _____ Care Coordination/Patient Safety
Q17.3 _____ Preventive Health
Q17.4 _____ At Risk population – Diabetes
Q17.5 _____ At Risk population – Hypertension
Q17.6 _____ At Risk population – Ischemic vascular disease (IVD)
Q17.7 _____ At Risk population – Heart failure (HF)
Q17.8 _____ At Risk population – Coronary artery disease (CAD)

Q18: What is your current position in the ACO?
____Chief Executive Officer (CEO)
____Chief Medical Officer (CMO)
____Chief Financial Officer (CFO)
____Chief Operations Officer (COO)
____Chief Technology Officer (CTO)
____Chief Information Officer (CIO)
____Chief Marketing Officer
____Other (PLEASE SPECIFY)
___________________________________________
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APPENDIX C: MEDICARE SHARED SAVINGS PROGRAM QUALITY
PERFORMANCE BENCHMARK FOR THE2014 REPORTING YEAR
Domain
Measure
30 th 40 th 50 th 60 th 70 th 80 th
perc. perc. perc. perc. perc. perc.
Quality points
1.1
1.25 1.40 1.55 1.70 1.85

90 th
perc.
2.00

Patient/Caregiver

ACO #1

30.00 40.00 50.00 60.00 70.00 80.00

90.00

Experience

ACO #2

30.00 40.00 50.00 60.00 70.00 80.00

90.00

ACO #3

30.00 40.00 50.00 60.00 70.00 80.00

90.00

ACO #4

30.00 40.00 50.00 60.00 70.00 80.00

90.00

ACO #5

54.71 55.59 56.45 57.63 58.22 59.09 60.71

ACO #6

72.87 73.37 73.91 74.51 75.25 75.82 76.71

ACO #7

N/A

ACO #8

16.62 16.41 16.24 16.08 15.91 15.72 15.45

ACO #9

1.75

1.46

1.23

1.00

0.75

0.56

0.27

ACO #10

1.33

1.17

1.04

0.90

0.76

0.59

0.38

ACO #11

51.35 59.70 65.38 70.20 76.15 84.85 90.91

ACO #12

30.00 40.00 50.00 60.00 70.00 80.00 90.00

ACO #13

17.12 22.35 27.86 35.55 42.32 51.87 73.38

ACO #14

29.41 39.04 48.29 58.60 75.93 97.30 100.00

ACO #15

23.78 39.94 54.62 70.66 84.55 96.64 100.00

ACO #16

40.79 44.73 49.93 66.35 91.34 99.09 100.00

ACO #17

30.00 40.00 50.00 60.00 70.00 80.00 90.00

ACO #18

5.31

ACO #19

19.81 33.93 48.49 63.29 78.13 94.73 100.00

ACO #20

28.59 42.86 54.64 65.66 76.43 88.31 99.56

ACO #21

30.00 40.00 50.00 60.00 70.00 80.00 90.00

Care
Coordination/
Patient Safety

Preventive Health

N/A

N/A

N/A

N/A

N/A

N/A

10.26 16.84 23.08 31.43 39.97 51.81
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Domain

Measure

Quality points

30 th
perc.
1.1

40 th
perc.
1.25

50 th
perc.
1.40

60 th
perc.
1.55

70 th
perc.
1.70

80 th
perc.
1.85

90 th
perc.
2.00

At-Risk
Population
Diabetes

Diabetes
17.39 21.20 23.48 25.78 28.17 31.37 36.50
Composite
ACO #2226
ACO #27
70.00 60.00 50.00 40.00 30.00 20.00 10.00

At-Risk
Population
Hypertension
At-Risk
Population IVD

ACO #28

60.00 63.16 65.69 68.03 70.89 74.07 79.65

ACO #29

35.00 42.86 51.41 57.14 61.60 67.29 78.81

ACO #30

45.44 56.88 68.25 78.77 85.00 91.48 97.91

ACO #31

30.00 40.00 50.00 60.00 70.00 80.00 90.00

At-Risk
Population HF
At-Risk
Population CAD

CAD
54.08 61.44 66.11
Composite
ACO #3233
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69.96 77.32 76.40 79.84
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APPENDIX D: MSSP ACO CHARACTERISTICS FROM A SURVEY CONDUCTED BY
THIS RESEARCH (N=61)
Variable
Mean/n
SD/%
Agreement with CMS
April 1, 2012
7
11.5%
July 1, 2012
12
19.7%
January 1, 2013
10
16.4%
January 1, 2014
17
27.9%
January 1, 2015
15
24.6%
The Average Number of Service Areas
1.36
.633
ACO Service Areas
Unemployment
6.89
1.71
Poverty
15.87
2.70
Market Competition Scores
.0024
.0043
The Time of Seeking Appropriate ACO’s Partners
Less than 1 year
46
75.4%
1 ~ 2 years
13
21.3%
More than 2 years
2
3.3%
The Facilitators Influencing Partners’ Willingness to Join an
ACO
Improvement of population health
4.16
.711
Improvement of patient quality of care
4.28
.636
A focus on the patient
4.08
.822
Physician-led
4.48
.698
Lower costs
3.85
.749
Shared savings
4.41
.901
Increased provider market niche/power
3.92
1.053
The Barriers Inhibiting Partners’ Willingness to Join an ACO
Legal and regulatory barriers
3.16
1.031
The mission of their own organizations
3.10
1.087
Anticipation of losing autonomy
3.43
1.078
Population base in not large enough
2.78
.966
Inadequate capital for information technology
3.69
1.046
improvements
Payment structure/financing
3.58
1.086
No ACOs in their areas to their knowledge
2.55
1.062
No ACOs in their area wish to partner with them at that
2.22
.974
time to their knowledge
Composition of ACO
Physician-led
24
39.3%
Hospital-based
36
59.0%
Missing
1
1.6%
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Variable
Total Number of Assigned Medicare Beneficiaries
5,001 – 7,500
7,501 – 10,000
10,001 – 12,500
12,501 – 15,000
15,001 – 17,500
17,501 – 20,000
> 20,000
Missing
Case Management
Yes
No
Missing
Current Position in the ACO
Chief Executive Officer
Chief Medical Officer
Chief Operations Officer
Other
Missing
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Mean/n

SD/%

14
7
6
10
3
4
13
4

23%
11.5%
9.8%
16.4%
4.9%
6.6%
21.3%
6.6%

50
7
4

82%
11.5%
6.6%

24
1
3
22
11

39.3%
1.6%
4.9%
36.1%
18%
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APPENDIX E: A DEGREE OF INFORMATION TECHNOLOGY AMONG MSSP
ACOS
Variable
Mean/n
SD/%
Type of Information Collection
Population data
52
85.2%
Clinical outcome data
47
77.0%
Financial performance data
53
86.9%
Productivity data
24
39.3%
Our ACO does not collect information for
1
1.6%
tracking and analysis
Other data
4
6.6%
The Status of Electronic Medical Records
(EMRs)
No partners have an EMRs
0
0.0%
< 20%
2
3.3%
21% - 40%
4
6.6%
41% - 60%
0
0.0%
61% - 80%
11
18.0%
> 80%
40
65.6%
Missing
4
6.6%
Information Infrastructure’s Functionalities (0
– 100 points)
ACO agreement start date
52.50
24.45
Currently
65.27
19.64
Information Infrastructure’s Usage Levels (0 –
100 points)
ACO agreement start date
49.49
24.31
Currently
65.19
22.73
Integration level of your clinical and
information system (0- 100 points)
ACO agreement start date
53.37
29.52
Currently
62.24
28.19
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APPENDIX F: ROGERS’ FIVE CORE CHARACTERISTICS AND OVERALL
ORGANIZATIONAL EFFECTIVENESS AMONG MSSP ACOS
Variable
n
Mean
SD
Executives Valuing the ACO
Model (0 - 100 points)
Overall
56
73.42
9.57
Relative advantage
58
79.66
13.66
Compatibility
59
86.61
8.48
Complexity
57
60.18
14.33
Trialability
56
73.64
14.08
Observability
57
69.12
23.32
Overall Organizational
44
70.03
12.22
Effectiveness (0 – 100 points)
Patient/Caregiver Experience
47
70.06
19.79
Care Coordination/Patient
47
68.91
21.41
Safety
Preventive Health
46
66.43
20.43
At Risk Population
Diabetes
46
71.67
17.51
Hypertension
45
70.49
15.62
Ischemic vascular disease
46
66.13
16.33
Heart failure
46
72.15
15.59
Coronary artery disease
46
71.65
14.83
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APPENDIX G: THE INITIAL MEASUREMENT MODEL OF THE ACTUAL ACO
PERFORMANCE: AN ENDOGENOUS LATENT VARIABLE (ETA_3) (STANDARDIZED
ESTIMATES).
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APPENDIX H: THE INITIAL MEASUREMENT MODEL OF THE ACTUAL ACO
PERFORMANCE
Items
Description
Standardized
Unstandardized
S.E.
Critical Value
Factor loading
Factor loading
AP1

Patient/caregiver
.260
Experience
AP2
Care
.524
Coordination/
Patient Safety
AP3
Preventive
.625
Health
AP4
Diabetes
.813
AP5
Hypertension
.628
AP6
Ischemic
.865
Vascular
Disease
AP7
Heart Failure
.378
AP8
Coronary Artery
.733
Disease
Chi-Square:64.566, DF: 20 ( P-value <.001)
* P-value < 0.05
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.584

.134

4.360*

1.475

.166

8.866*

2.238

.211

10.610*

1.387
.671
1.145

.100
.063
.079

13.837*
10.657*
14.582*

.232
1.000

.036

6.365*

APPENDIX I: PREDICTORS OF THE ACTUAL ACO PERFORMANCE:
AN INITIAL COVARIANCE STRUCTURE MODEL

126

APPENDIX I: PREDICTORS OF THE ACTUAL ACO PERFORMANCE: AN INITIAL
COVARIANCE STRUCTURE MODEL
SAMPLE SIZE: 317, CHI-SQUARE = 344.370, DEGREES OF FREEDOM = 82,
PROBABILITY LEVEL = <.001
NFI 0.758; CFI: 0.801; RMSEA: 0.101
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APPENDIX J: PREDICTORS OF THE ACTUAL ACO PERFORMANCE: AN INITIAL
COVARIANCE STRUCTURE MODEL
Independent Variable

Dependent Variable

Standardized
Parameter or factor
loading

Unemployment

Timing of Adoption of an
ACO Model

.653

Poverty

Timing of Adoption of an
ACO Model

HHI

S.E.

Critical
Value

117.718

7.445

15.811*

-.168

-15.761

3.874

-4.068*

Timing of Adoption of an
ACO Model

.011

462.339

1670.227

.277

The Number of
Assigned Medicare
Beneficiaries

Timing of Adoption of an
ACO Model

.065

.001

.001

1.583

Physicians-led

Timing of Adoption of an
ACO Model

.019

9.343

20.450

.457

Hospital-based

.019

9.534

21.177

.450

Unemployment

Timing of Adoption of an
ACO Model
Actual Performance

-.155

-.060

.029

-2.082*

Poverty

Actual Performance

-.182

-.037

.012

-3.178*

HHI

Actual Performance

-.148

-12.792

4.820

-2.654*

The Size of Assigned
Medicare
Beneficiaries
Physicians-led

Actual Performance

.219

.000

.000

3.878*

.023

.025

.059

.425

Hospital-based

Actual Performance

.137

.150

.061

2.455*

Timing of Adoption
of an ACO model

Actual Performance

.124

.000

.000

1.640

Actual Performance

AP1 (Patient/Caregiver
Experience)

.268

.589

.130

4.542*

Actual Performance

AP2 (Preventive Health)

.495

1.360

.161

8.449*

Actual Performance

AP3 (Preventive Health)

.607

2.122

.203

10.464*

Actual Performance

AP4 (Diabetes)

.814

1.354

.095

14.205*

Actual Performance

AP5 (Hypertension)

.667

.695

.069

10.050*

Actual Performance

AP6 (Ischemic Vascular
Disease)

.858

1.108

.074

14.898*

Actual Performance

AP7 (Heart Failure)

.372

.223

.035

6.334*

Actual Performance

AP8 (Coronary Artery
Disease)

.751

1.00

Actual Performance

Chi-squares: 344.370, DF: 82
* P-value < 0.05

(P-value < .001)
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Unstandardized
Parameter or
Factor loading
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